Jewish-Catholic relations, Jewish Studies
Aimee LaPointe Terosky
Urban Principals, Faculty careers, Women Faculty Advancement, K-12 Teaching and Learning, Higher Education Teaching and Learning
Doctor and neuroscientistKeywords:
Appetite, Obesity, Parkinson's Disease, Brain Imaging, music and the mind
Cardiovascular Disease, Lifebridge Health, Sinai Hospital, Cardiovascular Institute, Angiograms, Coronary Artery Disease, nuclear stress tests, Echocardiogram, Heart Failure, Heart Disease
Mental Health, Depression, Anxiety, Eating Disorders, PTSD, Insomnia, Sleep Disorders, Psychology
Professor and Chair of Pediatric DentistryKeywords:
Pediatric Dentistry, Dentistry, Dentistry and children, Oral Health
PTSD, Brain Function, Attention Training, National Science Foundation, NSF, MEG
Hair and Scalp Disease, Ethnic and Pigmented Skin Disease, Epidemiology of Skin Disease, Skin Care, Dermatology, Skin Cancer, Cosmetic Dermatology
Power, Energy, Smart Grid
Adam Gregerman, Ph.D., is an associate professor of Jewish Studies in the Department of Theology and Religious Studies and Associate Director of the Institute for Jewish-Catholic Relations at Saint Joseph’s University. His research focuses on the complex relationship between Jews and Christians from antiquity to the present. He published Building on the Ruins of the Temple: Apologetics and Polemics in Early Christianity and Rabbinic Judaism (Mohr Siebeck, 2016). His articles on biblical interpretation, mission and conversion, rabbinic theology, religious polemics, and theologies of the land of Israel have appeared in journals such as Theological Studies, Modern Theology, Interpretation, Cross Currents, Journal of Ecumenical Studies, and Studies in Christian-Jewish Relations. Dr. Gregerman has presented lectures in diverse settings, including academic conferences, synagogues, churches, and community centers, and taught in seminaries and universities. He is a member of the Committee on Ethics, Religion, and the Holocaust at the U.S. Holocaust Memorial Museum, Vice-Chair of the Council of Centers on Jewish-Christian Relations, and Academic Advisor to the National Council of Synagogues.
Aimee LaPointe Terosky, Ed.D., is an associate professor of educational leadership at Saint Joseph's University and the Director of the IDEPEL Doctoral Program. Dr. Terosky teaches courses in K-12 and Higher Education leadership at the doctoral and masters levels. Prior to her arriving at Saint Joseph's in January 2011, Dr. Terosky was an adjunct assistant professor of higher and postsecondary education at Teachers College, Columbia University, where she taught courses on teaching and learning and faculty development in postsecondary education settings. From 2006-2011, she also served as the assistant principal of Public School #334, The Anderson School in New York City, which received the 2007 New York City Blackboard Award for Outstanding Public Middle School. Areas of expertise: urban principals, faculty careers, women faculty advancement, K-12 and higher education teaching and learning
Doctor and neuroscientist
Appetite, Obesity, Parkinson's Disease, Brain Imaging, music and the mind
Dr. Alain Dagher is a neurologist specializing in movement disorders and functional brain imaging. His research aims at understanding the function of the basal ganglia, with a particular emphasis on appetitive behaviours. This involves studying how we learn about rewards and punishments, and become motivated to engage in reward-seeking behaviour. The two main techniques used are positron emission tomography (PET) targeting the dopamine system, and functional magnetic resonance imaging (fMRI). The research focusses on Parkinson's Disease, stress, drug addiction (notably cigarette smoking), pathological gambling, and obesity. Dr. Dagher is funded by CIHR, FRSQ, NIDA, the Parkinson Society of Canada, the Institute for Research on Pathological Gambling and Related Disorders, and Unilever PLC.
Dr. Tabrizchi’s medical expertise includes diagnostic angiograms, coronary interventions, peripheral angiograms and interventions, nuclear stress tests and echocardiograms.
Cardiovascular Disease, Lifebridge Health, Sinai Hospital, Cardiovascular Institute, Angiograms, Coronary Artery Disease, nuclear stress tests, Echocardiogram, Heart Failure, Heart Disease
Dr. Tabrizchi is a clinical interventional cardiologist at the LifeBridge Health Cardiovascular Institute in Maryland. He completed his fellowship at Winthrop-University Hospital. He did his residency at Washington Hospital Center, Children’s National Medical Center and National Institutes of Health (NIH). He completed medical school at Nova Southeastern University of College of Osteopathic Medicine. Dr. Tabrizchi is published in national and international medical journals.
Dr. Amit Shahane, PhD, is a clinical psychologist who serves as the director of the Behavioral Medicine Center at the University of Virginia Health System. Dr. Shahane specializes in treating psychological disorders, including PTSD, that impact medical illness. His research interests include examining the effectiveness of cognitive and behavioral treatments for insomnia, as well as healthcare utilization research, such as the effect of HIV stigma. UVA's Behavioral Medicine Center diagnoses, treats and prevents medical problems either caused or aggravated by lifestyle or stress, including: • Depression and anxiety • Migraine and tension headaches • Nervous stomach and irritable bowel syndrome • Sleep problems • Eating disorders Listen to Shahane discuss sleep problems: http://wina.com/morning-news/dr-amit-shahane-live-well/ Shahane discusses PTSD: http://www.newsplex.com/content/news/Fourth-of-July-fireworks-potential-PTSD-trigger-for-area-veterans-385267411.html
Amr M. Moursi, DDS, PhD, is a professor and chair of the Department of Pediatric Dentistry at NYU College of Dentistry. His research focuses on early childhood oral health, including the use of silver diamine fluoride (SDF) to fight cavities, birth defects of the head and skull, nutrition and oral health, and developing the pediatric dentistry workforce. Dr. Moursi is the author or co-author of more than 100 published articles, book chapters, and policy briefs, and is the editor of the textbook "Clinical Cases in Pediatric Dentistry" (Wiley-Blackwell). He is also a contributor for the 2020 U.S. Surgeon General’s Report on Oral Health. Dr. Moursi is a board-certified diplomate of the American Board of Pediatric Dentistry. He serves on the Executive Committee and as a National Spokesperson for the American Academy of Pediatric Dentistry (AAPD). He has extensive experience with print and broadcast media and is host of "The Dental Health Show" on Doctor Radio, SiriusXM satellite radio. Watch Dr. Moursi on ABC 7 discussing how to keep baby teeth healthy: https://youtu.be/ybKe5G1kodw
Dr. Badura Brack teaches Abnormal, Health, and Introductory Psychology, and she supervises the psychology internship program at Creighton University. Dr. Badura Brack is developing and testing a version of Attention Training Treatment that appears efficacious in treating combat-related Posttraumatic Stress Disorder (PTSD), as well as using magnetoencephalography (MEG) to identify regions where the brain functions abnormally in PTSD and determine if more normal neural functioning can be restored after attention training treatment.
Hair and Scalp Disease, Ethnic and Pigmented Skin Disease, Epidemiology of Skin Disease, Skin Care, Dermatology (general), Skin Cancer, Cosmetic Dermatology.
Hair and Scalp Disease, Ethnic and Pigmented Skin Disease, Epidemiology of Skin Disease, Skin Care, Dermatology, Skin Cancer, Cosmetic Dermatology
McMichael has published numerous articles and book chapters on the subjects of scalp and hair disorders and quality of life issues surrounding disorders of pigmentation. She is listed in Best Doctors in America and is a diplomat of the American Board of Dermatology. McMichael has served on several editorial review boards and is a contributing editor for Cosmetic Dermatology as well as a contributing editor for reviews in The Dermatologist.
Associate Professor; Director, Assistant Director
A breast surgeon, nationally recognized for her efforts in breast cancer care and research.
Breast Cancer, Yale Cancer Center, breast surgeon, hereditary breast and ovarian cancer syndrome breast cancer, Breast Neoplasms, Global affairs, Healthcare
Anees is the Director of The Breast Center, Smilow Cancer Hospital at Yale-New Haven, an Associate Professor in the Department of Surgery, Yale School of Medicine, and the Assistant Director for Global Oncology at Yale Comprehensive Cancer Center. Born and
Ann Morning, author of The Nature of Race: How Scientists Think and Teach about Human Difference (University of California), is an associate professor of sociology at New York University. She is a member of the U.S. Census Bureau National Advisory Committee on Racial, Ethnic, and Other Populations and has served as a statistician for the bureau. Morning has also authored reports for the National Research Council’s Committee on the Use of Social Science Knowledge in Public Policy and the United Nations’ Statistics Division. Morning is also the academic director of 19 Washington Square North, NYU Abu Dhabi’s home in New York. Morning previously worked as an economist at the Federal Reserve Bank of New York and as a diplomat in the U.S. Foreign Service. From 1995 to 1997, she was an Assistant Dean for Academic Affairs at Columbia University’s School of International and Public Affairs. Morning received her B.A. magna cum laude from Yale, her Master’s in International Affairs from Columbia, and her Ph.D. in sociology from Princeton. She also studied at the Institut d’Etudes Politiques in Paris.
Bailey’s research interests include African-American history; African and African Diaspora studies; history and memory; oral history; and civil rights. She writes and speaks about a variety of topics related to these research areas, including race, slavery, immigration, refugees, diasporas, faith and history and human rights. In her work, Bailey combines the elements of travel, adventure, history and an understanding of contemporary issues with an accessible style. Her works range from adult non-fiction to children’s historical fiction, and includes African Voices of the Atlantic Slave Trade: Beyond the Silence and the Shame (Beacon Press, 2005) and You Can Make A Difference: The Story of Martin Luther King Jr. (Bantam/Doubleday/Dell). Her newest book, The Weeping Time: Memory and the Largest Slave Auction in American History, was published by Cambridge University Press in October 2017 and has received very wide coverage.
Knott's research examines the optimal environment and policies (economic, industrial and firm) for innovation, and is best summarized in her book, How Innovation Really Works (March 2017). This interest stems from issues arising during an earlier career in defense electronics at Hughes Aircraft Company.
Targeting Cell Cycle Reactivation Caused by Inflammation May Provide the Way to Prevent Neuron Death in Alzheimer’s Disease
Italian-American Researchers Present Mediterranean Diet, Health, and Longevity at Annual Medical Conference
New Cancer Therapies Earn Sbarro Health Research Organization President Antonio Giordano 2017 CORE Prize for Oncology
From Medical Discovery to Food and Fine Arts, Italian-American Contributions Celebrated at Annual Foundation Conference
Diverse Role of CDK9 Gene in Cell Regulation Continues to Reveal Cancer Treatment Targets 25 Years After Discovery
Enzyme Inhibition May Lead to New Melanoma Therapy, Say Researchers at Fox Chase with Support from Sbarro Institute
Cervical Cancer During Pregnancy, Though Serious, is Highly Treatable According to New Research Review
Anurag Maheshwari, M.D., specializes in liver disease at The Center for Liver and Hepatobiliary Diseases, part of The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy in Baltimore, Maryland. His expertise helps patients seeking focused care for medical conditions of the liver. Dr. Anurag Maheshwari provides experience in treating a range of concerns involving the liver including hepatitis, liver cancer, cirrhosis and bile duct conditions. Dr. Maheshwari cares for patients in need of liver transplants and assists in pre- and post-operative transplant medical care, providing each patient individualized attention, coordination with liver transplant centers, and understanding as they progress toward recovery. Working with international authority Dr. Paul Thuluvath, Dr. Anurag Maheshwari is one of the physicians of The Institute for Digestive Health & Liver Disease at Mercy leading the way in the diagnosis and treatment of liver diseases. Dr. Anurag Maheshwari works collaboratively with the specialists of The Institute for Cancer Care at Mercy, The Center for Minimally Invasive Surgery at Mercy, The Center for Interventional Pain Medicine at Mercy, The Lung Center at Mercy, and the Division of Interventional Radiology. This comprehensive approach to diagnosis and treatment of digestive tract diseases and the expertise of our doctors makes The Institute for Digestive Health & Liver Disease at Mercy one of the best in Baltimore and the Mid-Atlantic region. Dr. Maheshwari has been named a "Top Doctor" in Gastroenterology/Liver Disease by Baltimore magazine. Dr. Anurag Maheshwari is active in advanced research projects in liver diseases. He has authored many peer-reviewed publications and book chapters on issues in liver disease. Dr. Anurag Maheshwari is an active speaker and has appeared at conferences and hospital grand rounds around the country. He has been published in: American Journal of Gastroenterology Digestive Diseases and Sciences Gastroenterology Hepatology Lancet Liver Transplantation Shakelford’s Surgery of the Alimentary Tract
Medical Director, The Institute for Cancer Care at
An internationally recognized expert and pioneer in the field of Hyperthermic Intraperitoneal Chemotherapy, Dr. Sardi is a surgical oncologist with expertise in treating late stage, complex cancers of the abdominal region. He is also involved in research.
Thyroid Cancer, Oncologist, Hyperthermic Intraperitoneal Chemotherapy, Cancer, medical director
Armando Sardi, M.D., is a respected and renowned Surgical Oncologist who has been honored as a Top Doc in Baltimore magazine multiple times. He serves as Medical Director of The Institute for Cancer Care at Mercy and as Chief of Division of Surgical Oncology at Mercy Medical Center in Downtown Baltimore, Maryland. Dr. Sardi is one of Maryland’s leading surgical oncologists who use Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late-stage, complex cancers of the abdominal region. Dr. Sardi has been performing HIPEC procedures since 1994 and is considered to be among the best doctors using the technique. This advanced heated chemotherapy procedure is often a life-saving treatment option for patients who have exhausted more traditional treatment plans for stomach cancer. Patients have traveled to Mercy Medical Center from points up and down the East Coast to destinations across the U.S., to seek out Dr. Sardi for his cancer expertise in the HIPEC treatment. Dr. Armando Sardi is a man whose professional focus is devoted to medical excellence, research and finding a cure for cancer. For his patients, Dr. Sardi’s personal concern and approach to their care are what helps them gain a positive outlook and confidence to face the challenges ahead. His cheerful smile and kind-hearted laugh immediately put patients at ease. And yet, his unyielding determination to give every patient the best possible chance to overcome their illness that ranks him among the best of the best. When other doctors have told patients there is no hope, Dr. Sardi tries even harder to beat the odds. Thanks to Dr. Sardi, the HIPEC procedure and other leading-edge treatment options, he has given patients so much more than hope. Patient after patient, year after year, have shared their stories at Mercy’s National Cancer Day Survivor Celebration and Mercy's annual Heat It to Beat It fundraising event. There are 3, 5, 10-year cancer survivors – each telling a heartwarming story of hope and survivorship. Dr. Sardi co-chair Mercy’s Cancer Committee and actively participates in The Tumor Board. These efforts allow cancer experts, specialists and key members of the healthcare team to discuss and collaborate on complex cancer cases to learn new and different ways to optimize resources, medical knowledge and treat patients so that long-term results will be improved. Dr. Sardi also plays a key role in the Mercy National Cancer Survivor Day festivities. This joyous and spirited celebration is more than a reunion of cancer survivors, it is a day when Dr. Sardi and the Mercy family rejoice with their patients and loved ones. Together they have been through a long and challenging cancer journey and together they delight in all the possibilities ahead. Dr. Armando Sardi, whose celebrated reputation has garnered local and international acclaim, has earned an international reputation for the advances he has made in the surgical oncology field and for his humanitarian efforts to care for the poor and underserved in third world countries. Dr. Sardi has been distinguished in Colombia, South America as one of the 100 Most Influential Expatriates – an honor received, in part, for the medical care he provides through the non-profit organization, Partners for Cancer Care and Prevention. This organization was the recipient of the Conquer Cancer Foundation's Inaugural International Innovation Grant. Dr. Armando Sardi has been recognized for his research, leadership and compassionate bedside manner. Some of his awards include: “Hispanic Hero Award for Excellence as a Medical/Social Entrepreneur” Presented by USHYEE “Gold Star Teamwork Award” Presented by The Sisters of Mercy in recognition of Gold Star performance Honored by Fusionarte as one of “100 Colombianos” who represent the talent, creativity, and perseverance of Colombia. Bogota, Colombia December 2012 Named by Baltimore Magazine a "Top Doctor" in the Surgical Oncology specialty Named by Castle Connelly Medical Ltd. a "Top Doctor" in Surgery Dr. Sardi founded the annual HEAT IT TO BEAT IT benefit walk in Baltimore to raise awareness about HIPEC and cancer treatment.
Dr. Johnson is a world-leading neuroscientist and pioneer in the development of medications for the treatment of alcohol abuse and is the inventor of all patents covering AD04. As Chief Medical Officer, Dr. Johnson joins the Adial senior management team as Adial prepares to commence a Phase 3 clinical trial of AD04 for people suffering from Alcohol Use Disorder (AUD). As one of the foremost leaders in the field of addiction medicine, Dr. Johnson was the initial United States-investigator who studied injectable naltrexone (Vivitrex, now Vivitrol) for the treatment of AUD, and pioneered the use of topiramate for AUD and other addictions; topiramate is now widely used for AUD. Notably, he made the landmark discovery that formed the scientific basis, using a precision medicine approach, for the utility of ondansetron as a treatment for AUD, and then conducted the pivotal Phase 2b clinical trial for this indication. That study indicated that ondansetron, now the lead compound for Adial (denoted as AD04 as referenced herein), has the potential to be an effective treatment for AUD among those with a specific genetic pattern in the serotonin system. Regarding his appointment as Adial's Chief Medical Officer, Dr. Johnson said, "I am delighted to join the senior management team of Adial as we work toward our goal of developing the leading addiction company. Given the tremendous progress at Adial and AD04's potential, due to the significant results it demonstrated in a rigorous Phase 2b trial conducted across four clinical sites in over 280 patients, it is the right time for me to expand my role with the company. AUD is a major global epidemic and is the leading cause of death for people aged between 15 and 49 years. I look forward to continuing my life-long quest to develop better treatments for addiction by helping Adial advance AD04 into Phase 3 trials and overseeing other expansion opportunities in the field of addiction." William Stilley, President and Chief Executive Officer of Adial Pharmaceuticals, commented, "We are honored that Dr. Johnson has agreed to serve as our Chief Medical Officer. As one of the preeminent addiction experts in the world, as well as developer of the intellectual property underpinning AD04, we expect he will be invaluable to the continued success of Adial, and we look forward to his ongoing contributions as our Chief Medical Officer. Dr. Johnson's tremendous clinical trial experience is fundamental to enhancement of our capabilities as we conduct our Phase 3 trial of AD04. Given his unique capabilities and relationships, and as the inventor of AD04, Dr. Johnson will assist Adial as we explore opportunities to expand the label for AD04 to include other addictions and pursue grants and strategic opportunities, including additional assets and therapies in the field of addiction." In August 2013, Dr. Johnson was appointed Chair of the Department of Psychiatry at the University of Maryland School of Medicine where he led the new Brain Science Research Consortium Unit. From 2004 until August 2013, he served as Chairman of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia and Alumni Professor. Dr. Johnson graduated in Medicine from Glasgow University in 1982 and trained in Psychiatry at the Royal London and Maudsley and Bethlem Royal Hospitals. In addition to his medical degree, he trained in research at the Institute of Psychiatry (University of London), and conducted studies in neuropsychopharmacology for his doctoral thesis (degree from Glasgow University) on the Medical Research Council unit at Oxford University. More recently, in 2004, Dr. Johnson earned his Doctor of Science degree in Medicine from Glasgow University-the highest degree that can be granted in science by a British university. His primary area of research expertise is the neuropsychopharmacology of medications for treating addictions. Dr. Johnson is a licensed physician and board-certified psychiatrist throughout Europe and in the United States. He is the Principal Investigator on National Institutes of Health (NIH)-funded research studies utilizing neuroimaging, neuropharmacology, and molecular genetics techniques. Dr. Johnson's clinical expertise is in the fields of addiction, biological, and forensic psychiatry. Honors include service on numerous the NIH review and other committees including special panels. Dr. Johnson was the 2001 recipient of the Dan Anderson Research Award for his "distinguished contribution as a researcher who has advanced the scientific knowledge of addiction recovery." He received the Distinguished Senior Scholar of Distinction Award in 2002 from the National Medical Association. Dr. Johnson also was an inductee of the Texas Hall of Fame in 2003 for contributions to science, mathematics, and technology, and in 2006 he received the American Psychiatric Association's (APA's) Distinguished Psychiatrist Lecturer Award. In 2007, he was named as a Fellow in the Royal College of Psychiatrists, and in 2008 he was elected to the status of Distinguished Fellow of the APA. In 2009, he received the APA's Solomon Carter Fuller Award, honoring an individual who has pioneered in an area that has benefited significantly the quality of life for Black people. In 2010, he was named as a Fellow in the American College of Neuropsychopharmacology. In 2013, Dr. Johnson was honored by the NIH as a recipient of the Jack Mendelson Award for work that has "transformed our understanding of how abnormalities of the brain promote addiction". And, in 2019, he is the recipient of the R. Brinkley Smithers Distinguished Scientist Award from the American Society for Addiction Medicine, which "recognizes and honors an individual who has made highly meritorious contributions in advancing the scientific understanding of alcoholism an, its prevention and treatment." Dr. Johnson was Field Editor-in-Chief of Frontiers in Psychiatry, serves on the Editorial Board of The American Journal of Psychiatry, and reviews for over 30 journals in pharmacology, neuroscience, and the addictions. He has over 200 publications and 15,459 citations (h-index = 56; see http://en.wikipedia.org/wiki/H-index). Dr. Johnson also has edited three books: Drug Addiction and Its Treatment: Nexus of Neuroscience and Behavior, Handbook of Clinical Alcoholism Treatment, and Addiction Medicine: Science and Practice, one of the foremost reference textbooks in the field. The second edition of Addiction Medicine: Science and Practice is scheduled to be released in 2019. Dr. Johnson has served as a consultant to Johnson & Johnson (Ortho-McNeil Janssen Scientific Affairs, LLC), Transcept Pharmaceuticals, Inc., D&A Pharma, Organon, Psychological Education Publishing Company (PEPCo LLC), and Eli Lilly and Company. He also has served on the Extramural Advisory Board for National Institute of Alcoholism and Alcohol Abuse (NIAAA) (2004-present), the National Advisory Council for National Institute of Drug Abuse (NIDA) (2004-2007), the Medications Development Subcommittee of NIDA's Advisory Council on Drug Abuse (2004-2007), and the Medications Development Scientific Advisory Board for NIDA (2005-2009). In addition, he has been the recipient of research grant support from both NIAAA and NIDA.
Bernard (Bernie) W. Chang, M.D., Director of Baltimore’s Plastic & Reconstructive Surgery at Mercy, also leads The Breast Reconstruction and Restoration Center at Mercy. Dr. Bernie Chang is Board Certified in Plastic Surgery and General Surgery. He pioneered and advanced surgical treatment options like DIEP flap surgery for breast reconstruction. With a skilled and highly specialized team of doctors, Mercy's Plastic Surgery and Breast Reconstruction Centers are known as one of the Mid-Atlantic’s best in breast reconstruction and restoration, cosmetic medicine and plastic surgery. As the Assistant Director of The Hoffberger Breast Center at Mercy in Baltimore, Dr. Bernie Chang works closely with the Breast Center doctors to provide seamless care for those women who choose immediate breast reconstruction after breast surgery. The industry-leading expertise of Dr. Chang and the renowned reputation of the physicians of The Breast Center result in choices that women may not find elsewhere. With more than 20 years of medical experience, Dr. Chang offers women peace of mind in breast reconstruction and restoration. His quiet thoughtfulness and attention to the needs of his patients provide a calming touch that helps each woman focus on her treatment options and recovery. His expertise is in helping women reclaim their feminine form and personal self-esteem after a diagnosis and treatment for breast cancer. Women say they have regained their physical and emotional balance in the care of Dr. Chang. Dr. Chang has performed DIEP flap breast reconstruction surgery for decades and his leadership is widely known. DIEP flap breast reconstruction surgery is one of the most widely performed breast shaping options for women. Dr. Chang is also skilled in other microsurgical flap procedures including: DIEP flap SGAP flap & Bilateral SGAP Flap IGAP flap TUG flap Latissimus flap Dr. Bernie Chang’s surgical expertise attracts surgical fellows from across the nation to train in the renowned Fellowship Program at Mercy in breast reconstruction and surgical flap treatment options.
Boris Kuvshinoff II
Chief Medical Officer
Liver cancer, pancreatic cancer, abdominal tumors, stomach cancer, gallbladder cancer, gastrointestinal cancer
Liver Cancer, Pancreatic, Cancer, Pancreatic Cancer, abdominal cancer , Gastrointestinal Cancer, Stomach Cancer, Gallbladder Cancer
Dr. Brian Anderson is a Harvard-trained physician-scientist, innovator, and digital health expert. Dr. Anderson’s focus is on the use of information technology in support of emerging clinical decision support (CDS) models and the provision of safe, effective, patient-centered care. While at Athenahealth, where he led the Informatics Department, Dr. Anderson launched a new model of CDS leveraging Artificial Intelligence (AI). He has served on several national health information technology committees in partnership with the Office of the National Coordinator (ONC). At MITRE, Dr. Anderson works on mCODE, a standardized data language and interoperability model for cancer research and treatment, as well as architecting, implementing, and analyzing health information systems for the Centers for Medicare and Medicaid Services (CMS), the Department of Health and Human Services (HHS), and the Department of Veterans Affairs (VA). He also sits on the ONC’s Health Information Technology Advisory Committee. Dr. Anderson has written in the Journal of Precision Medicine and spoken at the Precision Medicine Summit and HIMSS19.
Dr. Brian Charest's scholarship includes education reform, teacher education, engaged scholarship, education philosophy, teaching writing, the use of DIY subcultures in and out of schools, justice-oriented education, civic and community engagement, community organizing, grassroots education reform strategies, the prison-to-school pipeline (and the disruption of the school-to-prison pipeline), and the teaching of English. His university teaching has involved community-based work of some kind, where students in his courses worked closely with local community-based organizations, schools, practicing teachers, and residents in "real world" settings. Brian draws on the traditions of community organizers and activists to help teachers learn the skills and strategies to be strong advocates for themselves, their students, and the communities in which they live and work. Brian is an advocate for publicly funded education and supports efforts to empower marginalized groups and disrupt structural inequalities. He has presented locally and nationally and published articles on teaching, ecological schooling, civic engagement, community organizing, social justice, ethics, and radical pragmatism.
As the founding executive director of UCI’s multidisciplinary Cybersecurity Policy & Research Institute, Bryan Cunningham is focused on solution-oriented strategies that address technical, legal and policy challenges to combat cyber threats; protect individual privacy and civil liberties; maintain public safety, economic and national security; and empower Americans to take better control of their digital security. Cunningham is a leading international expert on cybersecurity law and policy, a former White House lawyer and adviser and a media commentator on cybersecurity, technology and surveillance issues. He has appeared on ABC, Bloomberg, CBS, CNN, FOX and other networks. Cunningham has extensive experience in senior U.S. government intelligence and law enforcement positions. He served as Deputy Legal Adviser to then-National Security Advisor Condoleezza Rice. He also served six years in the Clinton administration as a senior CIA officer and federal prosecutor. He drafted significant portions of the Homeland Security Act and related legislation, helping to shepherd them through Congress. He was a principal contributor to the first National Strategy to Secure Cyberspace, worked closely with the 9/11 Commission and provided legal advice to the President, National Security Advisor, the National Security Council, and other senior government officials on intelligence, terrorism, cyber security and other related matters. Cunningham is a founding partner of the Washington, DC-Los Angeles firm Cunningham Levy Muse, and his law practice has included assisting Fortune 500 and multinational companies to comply with complex legal regulations under U.S. federal law, myriad state laws and the numerous privacy and security requirements in the European Union and other overseas jurisdictions. He was founding vice-chair of the American Bar Association Cyber Security Privacy Task Force and was awarded the National Intelligence Medal of Achievement for his work on information issues. He has served on the National Academy of Sciences Committee on Biodefense Analysis, the Markle Foundation Task Force on National Security in the Information Age and the Bipartisan Policy Center’s Cyber Security Task Force. He is also the principal author of legal and ethics chapters in several cybersecurity textbooks.
Candace S. Johnson
President & CEO
cancer research, vitamin D, immunotherapy, cancer vaccines, genomics, personalized medicine, cancer therapies, medical research
Cancer, Cancer Research, Vitamin D, immunotheraphy, Cancer Vaccines, Genomics, Personalized Medicine, Cancer Therapies, Medical Research
Executive Director of the Center for Personalized
Genomics, personalized medicine, molecular pathology, cancer genetics, molecular diagnostics, medical diagnostics
Genomics, Personalized Medicine, molecular pathology, Cancer, Cancer Genetics, Molecular Diagnostics, Medical Diagnostics
Lipo’s research interests include studying the cultural change of human populations. Lipo uses evolutionary theory as a means of developing methods for studying cultural transmission and the process of natural selection, acting on cultural systems. His work has explored community patterning among prehistoric potters of the Mississippi Valley, patterns of inheritance among stone tools producers in North America and the conditions that led the populations of Easter Island (Rapa Nui, Chili) to construct their famous monumental statues. In addition to the study of artifact variability and geochronology, Lipo has interests in remote sensing, as a means of efficiently and non-destructively studying the archaeological record. This work includes the use of magnetometry, resistivity, conductivity, thermal imagery, photogrammetry, LiDAR and ground penetrating radar.
An assistant professor in the Department of Politics at Ithaca College’s School of Humanities and Sciences, Figueroa can discuss U.S. political issues, including presidential leadership, racial, religious and working class politics, U.S.-Puerto Rico policy, and immigration/border politics. Figueroa’s academic research focuses on American political development; race, religion and citizenship; Black American politics and political thought; Latino politics and border studies; public leadership; and U.S. Quakers. He is currently finishing a book on Quakers, race and U.S. Empire. His research also focuses on Bayard Rustin, a Black, gay, Quaker labor and civil rights activist of the 1940s through 1980s. He is also working on a project about the everyday “lived experiences” of people who study and/or work near the U.S.-Mexico border.
Dr. Hedrick's research is focused on understanding how the functions of immune cells, such as monocytes and T lymphocytes, change during the progression of cardiovascular disease and cancer.
Monocytes, Cancer, Cardiovascular Disease, T Lymphocytes, cancer metastasis, Heart Disease, Plaques, Immune Cells
Hedrick received her B.S. in Biology from Salem College in Winston-Salem, North Carolina in 1984. She received her Ph.D. in Biochemistry from Wake Forest University School of Medicine in 1992, where she performed her graduate research on LDL cholesterol metabolism in the laboratory of Dr Lawrence Rudel. From 1992 to 1995, she performed her postdoctoral research on HDL metabolism in the laboratory of Dr Aldons ‘Jake’ Lusis at UCLA. From 1995 to 1999, she worked as a junior faculty member in the Division of Cardiology at UCLA, where her research focused on inflammation and endothelial function. From 2000 to 2009, Dr. Hedrick worked as a professor in the Departments of Pharmacology, Medicine, and Molecular Physiology and Biological Physics at the University of Virginia in Charlottesville. In 2009, Dr. Hedrick was awarded the Harrison Chair of Molecular Physiology and Biological Physics at the University of Virginia. Dr. Hedrick joined the faculty of LJI in the Division of Inflammation Biology in 2009. Dr. Hedrick currently serves on the NHLBI Vascular Cellular Molecular Biology Review Committee, the AAI Committee for the Status of Women, and the American Heart Association ATVB Council Leadership Committee. She is also a Fellow of the American Heart Association. Recent honors received by Dr. Hedrick include the ATVB Vascular Biology Special Recognition Award, from the American Heart Association in 2013; the Jeffrey M. Hoeg Arteriosclerosis Thrombosis and Vascular Biology Award for Basic Science and Clinical Research from the American Heart Association in 2014; and the Arteriosclerosis Thrombosis and Vascular Biology Mentor of Women Award from the American Heart Association in 2015.
Minimally invasive and bariatric surgeon
Dr. Richardson’s areas of expertise include minimally invasive surgery, bariatric (weight loss) surgery, hernia surgery, appendectomy, gallbladder surgery, colon resection, gynecologic procedures, urological procedures.
Minimally Invasive Surgery, MIS, Bariatric Surgery, Weight Loss Surgery, Northwest Hospital, Lifebridge Health, Robotic Surgery, colon resection, gynecologic procedures, urological procedures, Gallbladder
Dr. Richardson practices in the Department of Minimally Invasive and Bariatric Surgery at Northwest Hospital and Sinai Hospital, both in Maryland. She completed her fellowship at Northwest Hospital and her residency at Emory University Hospital. She attended medical school at Wake Forest University School of Medicine. Dr. Richardson is also proficient in robotic surgery and general surgery. She also speak French (Canadian) and Spanish.
Professor; Director; Physician-in-Chief
An internationally recognized expert in gastrointestinal cancers and cancer epidemiology, Dr. Fuchs was previously professor of medicine at Harvard Medical School and chief of the gastrointestinal oncology division.
Colorectal Cancer, Gastrointestinal Cancer, Yale Cancer Center, Cancer epidemiology, Cancer Prevention and Control
Charles S. Fuchs, MD, MPH, became Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017. An internationally recognized expert in gastrointestinal cancers and cancer epidemiology, Dr. Fuchs was previously profess
Cheryl Healton, DrPH, is dean of the College of Global Public Health and professor of public health policy and management at New York University. A public health leader and scholar, Healton has published more than 100 peer-reviewed papers and special reports on topics including HIV/AIDS, the opioid crisis, public health education, health policy, substance abuse, and tobacco. Healton was the founding president and CEO of Legacy (now Truth Initiative), a national foundation dedicated to tobacco control created by the tobacco industry’s Master Settlement Agreement. Healton worked to further the foundation’s mission: to build a world where young people reject tobacco and anyone can quit. During her time with Legacy, Healton guided the national youth tobacco prevention counter-marketing campaign, truth®, which has been credited with reducing youth smoking prevalence to near record lows. Healton is currently focused on what lessons can be learned from the tobacco industry’s Master Settlement Agreement and applied to other public health issues, including opioids, gun violence, obesity, and global warming. https://www.nejm.org/doi/10.1056/NEJMp1802633
Chris Norwood, is a prize-winning author and healthcare advocate, was one of the first journalists to sound an alarm about HIV/AIDS in the early 1980s before it was widely recognized as a deadly epidemic. Norwood broke the story in Ms. Magazine that women with AIDS were routinely undercounted with their deaths attributed to other causes. She also authored the first book on women and HIV, “Advice for Life: A Woman’s Guide to AIDS.” That book, which came out in 1987, became the inspiration for her founding Health People (then known as Health Force) in 1990 as a women’s prevention and support program. A pioneer in using peer education to enable communities to take control of their health, Chris has been recognized nationally and internationally for her work in HIV/AIDS and peer-delivered health education. In 2005, Chris was one of 1,000 women nominated worldwide for a special Nobel Peace Prize for women’s work in community health. She is a member of the Community Coordinating Council for the Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities (Bronx CREED), an NIH-funded Center of Excellence at the Albert Einstein College of Medicine; the Bronx-Einstein Alliance for Tobacco-Free Health (Bronx BREATHES); the Community Advisory Board of Albert Einstein College of Medicine AIDS Research Center; and the Chronic Disease Prevention Group of the NY State Health Department Prevention Agenda Committee. She is also a past member of the Board of Directors of the Public Health Association of New York City. Chris has contributed extensively to research on community health issues. She is a graduate of Wellesley College. See LinkedIn: https://www.linkedin.com/in/chris-norwood-b0a2316/
Division Head, Minimally Invasive Surgery
Expertise includes laparoscopic gastric bypass, laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding, as well as other minimally invasive surgery procedures.
laparoscopic gastric bypass, laparoscopic sleeve gastrecomy, laparoscopic adjustable gastric banding, Minimally Invasive Surgery
Dr. Christina Li received her medical degree from the Columbia College of Physicians and Surgeons. She completed her residency in general surgery at the University of Maryland and was also a research fellow at the Maryland Center for Videoscopic Surgery. She completed a fellowship in minimally invasive and bariatric surgery at the University of Pennsylvania. She has been performing bariatric surgery for LifeBridge Health since 2004 and is a founding member of Sinai Hospital's Bariatric Center for Excellence.
Director, UCLA Steve Tisch BrainSPORT Program
Sports concussion, traumatic brain injury and pediatric neurocritical care.
Concussion, concussion and football, traumatic brain injuries, Youth, Neuroplasticity, post-traumatic epilepsy, concussion and sports, Sports-Related Head Injury, Brain Development, helmet studies, Neuroimaging, Genetic Markers
Before joining UCLA, Giza worked on the Yosemite Search and Rescue team. In 2011, he traveled to Afghanistan as a civilian advisor to the U.S. Department of Defense. He co-chaired the American Academy of Neurology committee that developed an evidence-based practice guideline for the management of sports concussions from 2009-2013. He currently serves on advisory committees for traumatic brain injuries/concussion with the U.S. Centers for Disease Control, National Collegiate Athletic Association, Major League Soccer and U.S. Soccer Federation. He has been a clinical consultant for the National Football League, National Hockey League and Major League Soccer.
Dr. Christopher Ohl is an infectious disease specialist in Winston Salem, North Carolina and is affiliated with multiple hospitals in the area, including Wake Forest Baptist Health-Lexington Medical Center and Wake Forest Baptist Medical Center. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice for more than 20 years.
Assistant Research Professor
Global health security policy and implementation, Neglected tropical disease control, Malaria policy and advocacy One Health (the interface between human, animal, and environmental health), with a focus on zoonotic diseases
Assistant research professor in the Center for Global Health Science and Security. She can address the importance of global frameworks supporting health systems strengthening for public health emergency preparedness and response, and particularly those focused on preventing infectious disease outbreaks. In the context of Ebola, she can speak to her professional experience of supporting public health capacity building during and immediately after the West Africa outbreak (Guinea) and the importance of communication and coordination among multisectoral partners on a national, regional and global level.
Medical Director, The Institute for Foot and Ankle
Foot and Ankle Reconstructive Surgery, Arthritis of the Foot, Athletic Injuries, Bunions, Diabetic Foot Care, Foot and Ankle Surgery, Trauma, and Care
Orthopedic Surgery, Arthritis, Athletic Injuries, Reconstructive Surgery
Clifford L. Jeng, M.D., is Medical Director of The Institute for Foot and Ankle Reconstruction at Mercy Medical Center and an award-winning foot and ankle surgeon. Patients from Baltimore and across the Mid-Atlantic region come to Dr. Jeng for his expertise in foot and ankle injuries and conditions.Dr. Clifford Jeng leads a talented team of surgeons who offer innovative treatments for complex foot and ankle issues as well as comprehensive treatment for common foot and ankle conditions. As a long-standing member of the physician team, Dr. Jeng has invested over a decade in The Institute and continues to carry on the legacy of excellence as its Medical Director. Built on a foundation of continued education and innovation to benefit patient care, The Institute for Foot and Ankle Reconstruction at Mercy remains a leading Center of Excellence in complete foot and ankle care including treatment for ankle injury and Achilles tendon problems, foot injury and conditions, big toe and smaller toe problems, heel injury and diabetic foot conditions.Dr. Jeng and his team offer comprehensive initial visits as well as second opinions. Physicians and patients alike value Dr. Jeng's expert opinion and hopeful patients have been known to travel long distances to be evaluated and cared for by Dr. Jeng. Various media outlets and television stations also rely on Dr. Jeng to provide thorough analysis and explanation of foot and ankle conditions as well as information on the latest technologies and techniques offering new hope to patients with complicated foot and ankle injuries or problems. Dr. Jeng has been recognized as a Top Doc by Baltimore magazine multiple times. Board Certified, Dr. Jeng has specialized training in advanced surgical techniques, including minimally invasive surgery and arthroscopy. Dr. Clifford Jeng established the prestigious Foot and Ankle Fellowship program at Mercy and has trained peers and elite orthopedic surgeons. Following the spirit and mission of the Sisters of Mercy, Dr. Clifford Jeng is dedicated to providing foot and ankle care to the less fortunate in the Baltimore community. Dr. Jeng, along with fellow surgeons Dr. John Campbell and Dr. Rebecca Cerrato, has volunteered foot care services during an annual event for homeless men who find refuge at Baltimore’s Helping Up Mission. Additionally, Dr. Jeng has regularly participated in Baltimore's Run to Remember, running alongside colleagues, patients and Baltimore residents to honor the heroes of 9-11 and raise money for The Baltimore City Police Foundation and The Baltimore City Fire Foundation.
WASHINGTON, DC - Ambassador Clint Williamson is the Senior Director for the International Rule of Law and Security program at the McCain Institute for International Leadership at Arizona State University and a professor of practice at the Sandra Day O’Connor Law School at Arizona State University. Amb. Williams previously served as Chief Prosecutor of the EU Special Investigative Task Force from 2011 to 2014, Special Expert to the Secretary-General of the United Nations from 2009 to 2011, and U.S. Ambassador-at-Large for War Crimes Issues from 2006 to 2009. Amb. Williams is available for comment on global affairs, human rights, and international law. He can be reached for comments at John.C.Williamson@asu.edu
Colleen Cicchetti, PhD, is a national expert on care for children and adolescents who have experienced trauma. She can advise parents on how to talk to children after a school or mass shooting. She can discuss bullying and mental health issues.
Violence, School Shooting, mass shooting, Bullying, Mental Health
Colleen Cicchetti, PhD, is a pediatric psychologist at Ann & Robert H. Lurie Children's Hospital of Chicago and an Assistant Professor in Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. She is the Executive Director of the Lurie Children's Center for Childhood Resilience, which promotes access to high quality mental health services for children and adolescents statewide through clinical service, research, training, advocacy, and policy reform. She is a leader in trauma-informed care, training staff in the Chicago Public Schools on how to help youth who have experienced trauma or have other mental health issues. She was awarded the Public Educator of the Year award by the National Alliance on Mental Illness.
Expertise includes ankle, foot and leg injuries; knee ailments including arthritis, ACL tears; cartilage defects and damage; Hip damage; Shoulder ailments including rotator cuff tears; labral cartilage damage; shoulder instability
Sports Injuries, Acl Tears, cartilage damage, hip damage, Rotator Cuff Tears, shoulder instability
Dr. Bennett is a board-certified orthopedic surgeon, fellowship-trained in sports medicine, with more than 20 years of orthopedic surgery experience. He has provided medical care to teams at every athletic level, most recently serving as the director of sports medicine at the University of Maryland, where he was the team orthopedic surgeon for University of Maryland athletics. He has treated a number of NFL and Division 1 college athletes, helping them return successfully to their sports.
Damion A. Martins, MD, is board-certified in sports medicine and internal medicine, and currently holds positions as the Medical Director of Sports Medicine, Director of the Executive Health and Program Director of the Sports Medicine Fellowship at Atlantic Health System. Dr. Martins is an accomplished national leader in Sports Medicine with a proven track record in hospital administration. He not only treats thousands of professional and collegiate athletes, but develops the programs that enhance their performance. Dr Martins successfully oversaw a complex Orthopedic service line, consisting of 200+ physicians, covering five hospitals where he doubled both volume and revenue while increasing access and patient satisfaction. He was instrumental in developing Atlantic Health System’s Sports Cardiology and Sports Performance programs as well as the first Accountable Care Organization (ACO) designated Sports Medicine Center of Excellence. These programs have earned national quality recognition as Top 50 Orthopedic programs by U.S. News & World Report, 5 Star by Healthgrades and top 5% nationally for overall Orthopedic services. As a recognized leader in the area of sports performance and exercise testing, Dr. Martins lectures extensively in the field of sports medicine. He is consistently recognized as a “Top Doctor” by Castle Connolly and is renowned for his research in hydration, musculoskeletal injuries and concussions. He is currently involved in a number of active research studies. His expertise has lent itself to the development of cardiovascular training programs widely used in the fitness industry and corporate wellness. He has authored over fifty publications including book chapters on the pre-participation exam and medical conditions that limit sports participation. Dr. Martins is the director of internal medicine and team physician for the National Football League’s (NFL) New York Jets where he has served as a medical consultant since 2002, and member of the NFL Team Physician Society. As a former National Hockey League (NHL) Team Physician and member of the NHL Advisory Committee, he was instrumental in the development of the current National Hockey League’s pre-participation guidelines. His extensive experience on both the professional and collegiate levels also includes administrative medical director for Major League Soccer (MLS) and medical coverage for the U.S. Open Golf Championship, U.S. Open Tennis Championships, New York Islanders, New York Dragons, Hofstra University, and the College of St. Elizabeth. He is currently a medical advisor for New Jersey Interscholastic Athletic Association and Parisi Speed School. Dr. Martins has dual academic appointments at Mount Sinai School of Medicine as assistant clinical professor in the departments of both medicine and orthopedics. He developed and is currently the program director of the American College of Graduate Medical Education (ACGME) accredited Sports Medicine Fellowship at Atlantic Health. Dr. Martins graduated from Georgetown University School of Medicine, where he also obtained his Master’s degree in Exercise Physiology and Biophysics. He completed residency training in internal medicine at Georgetown University Medical Center. He completed his fellowship in sports medicine at the University of Maryland, where he served as fellow team physician for the NFL’s Baltimore Ravens and University of Maryland’s Terrapins.
Epps is a nationally recognized expert on the Supreme Court. A former law clerk to Supreme Court Justice Anthony Kennedy, Epps focuses on criminal law and criminal procedure – and his scholarly approach draws upon history, philosophy, political science and economics. His research analyzes the criminal justice system using the tools and insights of structural public law and institutional design; he also researches and writes about constitutional theory and federal courts. His scholarship has appeared in the Harvard Law Review, the Yale Law Journal, the Michigan Law Review, and the NYU Law Review, and his writing for popular audiences has appeared in the New York Times Magazine, the Washington Post, Vox and The Atlantic.
Darren Hudson is a professor and the Larry Combest Endowed Chair for Agricultural Competitiveness and Director of the International Center for Agricultural Competitiveness and the Cotton Economics Research Institute at Texas Tech University since 2008. Hudson’s research interests include agricultural policy and trade, economic development, marketing and consumer demand, and behavioral economics. He participates in the Food and Agricultural Policy Research Institute consortium producing annual baseline projections for cotton for the group. Hudson is a past-President of the Southern Agricultural Economics Association an also is a member of the American Agricultural Economics Association. Hudson earned his bachelor's degree in Agribusiness from West Texas A&M University and his master's and doctoral degrees in Agricultural and Applied Economics from Texas Tech University.
David Powner is Director of Strategic Engagement and Partnerships, and previously was the Director of Information Technology Management Issues at the U.S. Government Accountability Office (GAO) and has 25 years of experience in the public and private sectors. He is an expert on IT modernization and the role of the CIO in the federal government. Powner has appeared on Government Matters, in the Federal Times and has testified in front of Congress more 100 times. He has also written in FCW. Among his many achievements, Powner played a key role in the implementation of the Federal Information Technology Acquisition Reform Act (FITARA), led the creation of the FITARA Scorecard, and contributed his expertise and insights to the development of the Modernization Government Technology Act.
Endowed Chair in Psychiatric Nursing
Dr. Gross specializes in psychology and mental health nursing, child psychology, and early childhood intervention. She developed the innovative Chicago Parent Program, which improves parenting behavior and reduces child behavior/mental health problems.
Mental Health, mental health and children , Parenting, Parenting Advice, parenting intervention, Child Psychology, Suicide, Research, Nurse, Nursing, Johns Hopkins, Chicago Parent Program, Behavior, Behavior Problem, Community Health, Public School, Psycho
Deborah Gross is best known for her work in promoting positive parent-child relationships and preventing behavior problems in preschool children from low-income neighborhoods. At Johns Hopkins, she holds joint appointments at the School of Nursing, the Department of Psychiatry and Behavioral Sciences in the School of Medicine, and the Department of Mental Health in the Bloomberg School of Public Health. Previously, as associate dean for research and a department chair at Rush University College of Nursing, Dr. Gross and colleagues developed the innovative Chicago Parent Program, which improves parenting behavior and reduces child behavior problems. The program currently is used in a number of settings, including Head Start centers in Chicago and New York City. Dr. Gross was a Robert Wood Johnson Executive Nurse Fellow, and among her many recognitions are the Friends of the National Institute for Nursing Research President's Award for outstanding research, the American Academy of Nursing Edge Runner award honoring developers of model programs offering solutions to healthcare challenges, and induction into the Sigma Theta Tau Researchers Hall of Fame. She has served on numerous review panels for the National Institutes of Health and the Institute of Medicine, published more than 100 articles, book chapters, and abstracts, and currently serves on the editorial board of Research in Nursing & Health and Nursing Outlook.
Deborah Buckles (formerly Hudson) is the program director of the Tobacco Treatment Program at the Indiana University Melvin and Bren Simon Cancer Center in Indianapolis. In 2018, the IU Simon Cancer Center was awarded a two-year, $500,000 grant from the National Cancer Institute for the Cancer Center Cessation Initiative, created to expand existing efforts at NCI-designated cancer centers to help tobacco-using patients quit smoking. Buckles is an expert on smoking cessation and is available to talk about nicotine addiction and the best ways to stop smoking. She can also comment on vaping and e-cigarettes, including common misconceptions about the safety and use of these products. On the topic of recent vaping-related respiratory illnesses and deaths, Buckles says: - Vaping is not proven to be safer than smoking cigarettes. There are still a lot of health questions about vaping that need answers. - Pulmonary incidents and respiratory illnesses have occurred in people that have vaped nicotine, as well as those who have vaped THC. - E-cigarettes are regulated by the FDA as tobacco products, but that does not mean they are FDA approved.
Deborah A. Pasko
Sr. Director, Medication Safety & Quality
Pharmacist available to comment on opioid misuse and medication safety
drug shortages, Opioids, Medication Safety, Patient Safety, Pediatrics, Critical Care, hospital administration, Healthcare, Pharmacy, Polypharmacy
Deborah A. Pasko, Pharm.D., M.H.A., is the Sr. Director of Medication Safety and Quality at ASHP (American Society of Health-System Pharmacists). With more than 22 years of pharmacy practice experience, Dr. Pasko leads ASHP’s efforts to improve medication safety and reduce opioid misuse.
Dr. Pasko’s role at ASHP includes working with the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Department of Health and Human Services (HHS), and the White House on national medication safety initiatives. She also serves as an advisor to the Institute for Safe Medication Practices (ISMP), the Joint Commission (TJC), the United States Pharmacopeia (USP) National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) safety committee, and the National Quality Forum (NQF).
Dr. Pasko earned her Bachelor of Pharmacy degree from the Ohio Northern University College of Pharmacy and her Doctor of Pharmacy degree from Idaho State University College of Pharmacy. She has a Masters of Health Administration from the Walden University School of Health Sciences and completed a fellowship in Nephrology and Critical Care at the University of Michigan College of Pharmacy. Dr. Pasko has received numerous awards including the Cheers Award for Medication Safety.
Board certified rheumatologist and a clinical scientist whose area of research is in both the pharmacological and non-pharmacological management of persistent pain. Dr. Ang has been the primary investigator of three National Institute of Health (NIH)-funded clinical trials in fibromyalgia. He has approximately 25 publications in peer reviewed journals in arthritis and pain. Dr. Ang has served as an ad hoc reviewer for NIH, and also a reviewer of research abstracts for the American College of Rheumatology (ACR). He is an active member of both the ACR and the American Pain Society.
Dermatology, skin, Nails, hair, Skin Cancer, Melanoma, Basal Cell Carcinoma, Squamous Cell Carcinoma, Atopic Dermatitis, Eczema, Psoriasis, Acne, Rosacea, Sun Protection, Indoor Tanning, Skin Diseases, Skin Conditions, Skin Disease, skin condition, Contact
Dr. Donald Anderson is the Director, U.S. National Office for Harmful Algal Blooms and a Senior Scientist at the Woods Hole Oceanographic Institution. His lab studies species of toxic algae responsible for disrupting human and ecosystem health. While some of these organisms create the phenomena commonly known as “red tides,” others can be less visible while still causing illness. From the Caribbean to the Arctic, his team is working to understand the factors that drive these harmful algal bloom (HAB) events. Lab: https://www2.whoi.edu/site/andersonlab/
Expertise includes glaucoma: diagnosis, treatment and surgery; cataracts: diagnosis and management (complicated patients); cataract surgery
Donald Abrams, MD, Krieger Eye Institute, Sinai Hospital, Lifebridge Health, Cataract, Glaucoma, ophthmology, eye treatment
Dr. Abrams has practiced at Sinai Hospital of Baltimore for more than 30 years. He has been chairman of ophthalmology at the Krieger Eye Institute at Sinai for more than a decade. Dr. Abrams earned his undergraduate degree from Lehigh University, attended medical school at the Medical College of Pennsylvania, completed his residency at Sinai Hospital of Baltimore and his fellowship at Dohney Eye Institute, USC in glaucoma.
Donald Nieman is Binghamton University’s Provost and Executive Vice President for Academic Affairs and also Professor of History. His research focuses on law, race, and civil rights in U.S. history, emphasizing the role that African Americans have played in using law and the Constitution to expand the nation’s understanding of citizenship, rights, politics, and the Constitution.
Professor, Department of Microbiology, Immunology
Gene therapy for genetic blood diseases such as adenosine deaminase-deficient severe combined immunodeficiency (also known as ADA-SCID or bubble baby disease), X-linked chronic granulomatous disease and sickle cell disease.
Adenosine, X Linked Diseases, Bubble Boy Disease, Sickle Cell Disease, Genetic Disease, Gene Editing, Gene Therapy, Stem Cell, Stem Cell Therapy
Donald B. Kohn, M.D., studies the biology of blood stem cells, which are located in the bone marrow and have two important properties: they can duplicate themselves and they can create all types of blood cells. Over the course of 30 years of research, Kohn has developed new clinical methods to treat genetic blood diseases using blood stem cells that have been modified to remove genetic mutations. Kohn’s blood stem cell gene therapy method collects some of a patient’s own blood stem cells and either adds a good copy of the defective gene or fixes the broken genes to eliminate disease-causing mutations. The patient then receives a transplant of their own corrected stem cells, which will ideally create an ongoing supply of healthy blood cells. Importantly, this method eliminates the risk of rejection associated with receiving a bone marrow transplant from a different person, meaning the patient doesn’t have to take a lifelong supply of anti-rejection drugs. Kohn’s clinical trials for adenosine deaminase-deficient severe combined immunodeficiency (also known as ADA-SCID or bubble baby disease), a condition where babies are born without an immune system and often don’t survive past the first two years of life, have cured more than 40 babies to date. Babies with the condition and their families have traveled to UCLA for this life-saving treatment from as far away as Lebanon and a new company was formed in 2016 to further develop the therapy and make it available at other centers and to more patients. Kohn is now applying similar blood stem cell gene therapy techniques in clinical trials for two other diseases. One of these diseases is X-linked chronic granulomatous disease, a rare inherited immunodeficiency disorder that prevents white blood cells from effectively killing foreign invaders such as bacteria, fungi or other microorganisms. If untreated, patients often succumb to chronic granulomatous disease within the first decades of life. The second disease is sickle cell disease, the most common inherited blood disorder in the United States. This disease causes abnormal ‘sickle-shaped’ red blood cells that block small blood vessels and do not provide the appropriate amount of oxygen to the body, resulting in debilitating pain and organ damage. Kohn’s clinical trial seeks to overcome or repair the genetic mutation that causes this devastating disease, which impacts millions worldwide. Kohn earned his bachelor’s and master’s degrees from the University of Illinois, Champaign-Urbana and his medical degree from the University of Wisconsin School Of Medicine. He completed a pediatric internship and residency in Wisconsin followed by a medical staff fellowship in the Lymphoid Malignancies Branch (formerly the Metabolism Branch) of the National Cancer Institute. Kohn began working on gene therapy as a fellow at the National Institutes of Health in 1985 and then began practicing as a pediatric bone marrow transplant physician at Children’s Hospital Los Angeles in 1987. While practicing at Children’s Hospital Los Angeles, he started his own lab focused on stem cell research and has continued this work, advancing new therapies from the lab to the clinic.
Trade, trade and transportation, Supply Chain, Supply Chain & Logistics Management, Supply Chain Management, Business, Tariff, Tariffs, Cold Chain, Lean & Process Improvement, transportation logistics, Operations Management, Production and Operations Manag
Douglas Hales is an Associate Dean and Professor of Supply Chain Management at the University of Rhode Island. His primary teaching expertise is Global Supply Chain Management and Lean Six Sigma. His research interests include Global Port Competitiveness and Applied Process Improvement. Hales has more than 20 years of operational and supply chain management experience for the U. S. Marine Corps as well as the plastics and construction industries. He can speak to the impact of U. S. imposed tariffs on Chinese goods and U. S. goods in many industries. He can discuss the delay between the tariffs and the arrival of goods being shipped to the U.S. and what consumers can expect, in terms of the timing of price hikes on goods purchased by Americans. He can discuss the “cold chain,” agricultural goods, electronics and commodities in general that ship by container vessel. Hales is a special issue co-editor for the Transportation Journal on Seaport Competition for 2018 and 2019, as well as the past Program Chair of the Northeast Decision Sciences Institute. He is also the incoming President of the Northeast Decision Sciences Institute, beginning July 1, 2019. https://web.uri.edu/business/meet/doug-hales/
Dr. Christopher J. Johnson received his Ph.D. in Sociology with a major in Aging and Family and minor in Social Psychology from Iowa State University, Sociology with major in Aging and Family. He earned his M.A. from University of Northern Iowa in Sociology with major in Aging. He earned his B.A. in Philosophy from the University of Denver. In research, besides procuring over 3 million dollars in grant and private funding, his interests are in dementia and marriage, design for dementia, suicide, thanatology and religiosity and aging. At his previous university, he was twice awarded “Researcher of the Year” in the School of Arts and Sciences. He has conducted a state-wide needs assessment of elderly in Iowa but specializes in oral histories. He was awarded an, Endowed Professorship in Gerontology based upon his outstanding teaching and research skills.
Educational Background B.S. in Chemistry 1991 Texas State University; Advisor: Dr. Patrick E. Cassidy M.S. in Chemistry 1993 Texas State University; Advisor: Dr. Patrick E. Cassidy Ph.D. in Organic Chemistry 1998 University of Florida; Advisor: Dr. John R. Reynolds Post-Doctoral Fellow; 1998-2000, Sandia National Laboratories, Livermore, CA
Larry Fulton is an Associate Professor of Health Administration at Texas State University, San Marcos. He earned his Doctorate of Philosophy / Masters of Science in Statistics from the University of Texas at Austin, his Master of Health Administration from Baylor, and three other graduate degrees. Dr. Fulton is a Fellow of the American College of Healthcare Executives (FACHE) and maintains the credentials of Chartered Scientist and Chartered Statistician (CStat CSci) as a Fellow in the Royal Statistical Society. He is a Certified Analytics Professional (CAP) of the Institute for Operations Research & Management Science, a Certified Quality Engineer and Certified Six Sigma Black Belt (CQE CSSBB) of the American Society for Quality and a Professional Statistician (PStat) of the American Statistical Association.
Nonverbal Communication,, Family Communication , Relational Communication, Interpersonal Communication, Family Communication , End Of Life, "Final Conversations", verbal and nonverbal messages, terminal diagnosis
Dr. Keeley was born and raised in Tucson, AZ ; she comes from a large Irish American family filled with civil servants (police officers, fire fighters, and nurses) and believes that her work as a Professor (scholar and teacher) has the same service goal as those distinguished professions: to help others and to improve lives. She is happily married and they have a son and a daughter.
Research in the Biomaterials and Nanomedicine Laboratory focuses on capturing the promise of nanomaterials for the development of new strategies for the detection and treatment of diseases. Specifically, our group develops functional nanostructures that can act as highly specific contrast agents for bioimaging, in vitro and in vivo biosensors, targeted and intracellular drug delivery systems, and stimuli controlled delivery systems. These responsive nanomaterials incorporate functional nucleic acid linkers, enzymatically cleavable linkers, polyelectrolytes, and amphiphilic copolymers to mediate physico-chemical changes in the polymeric networks upon interaction with target molecules, leading to the desired material response. Work in the laboratory encompasses the synthesis and characterization of copolymers and nanoparticles, in vitro confirmation of stimuli-responsive behavior, and the evaluation of the particle functionality on cultured human cells. Dr. Betancourt’s group collaborates with academic and industrial researchers for preclinical evaluation of the compatibility and efficacy of the developed biomaterials and technology transfer. Current projects in Dr. Betancourt’s laboratory include the development of: (1) aptamer-based responsive nanostructures that can be activated by disease-specific molecules, and on the study of the applications of these functional materials in targeted drug delivery, bioimaging, and biomolecular sensing; (2) highly specific nanoparticle-based near infrared contrast agents and drug delivery systems for optical detection and treatment of cancer; (3) photoablation agents and biosensors based on conductive polymers.
> Member of the Personnel Committee from August 2015-Present > Member of the Texas State University Alcohol and Drug Advisory Council from August 2014-Present > Member of the Texas State University Institutional Animal Care and Use Committee from August 2010-Present
Dr. DeSimone received his B.S., M.S., and Ph.D. degrees from Temple University in Philadelphia. He has worked in both community and hospital practice. He also served as a consultant to the FDA, USP, and the pharmaceutical industry. He has been a Contributing Editor for U.S. Pharmacist since 1996. Dr. DeSimone has published more than 70 professional papers and has had chapters in three different textbooks. He taught at Butler University for 12 years and has been on the Creighton faculty since 1989. He serves as Professor of Pharmacy Sciences and currently teaches Calculations in Pharmacy Practice as well as a course on addiction and substance-related disorders.
Dr. Soriano’s areas of expertise in pain management include: arthritis; back, knee, shoulder and neck pain; post-stroke pain; sciatica; post amputation pain; carpal tunnel syndrome; overuse injuries
Pain Management, interventional pain management, Back Pain, Neck Pain, Shoulder Pain, post stroke pain, Knee Pain, Sciatica, post amputation, Carpal Tunnel Syndrome
Dr. Soriano is an expert in pain management, interventional pain management, and physical medicine and rehabilitation. He treats patients at The Center for Pain Treatment and Regenerative Medicine at LifeBridge Health in Maryland. Dr. Soriano completed his residency at Temple University Hospital, his internship at Kennedy memorial Hospital and earned his medical school degree from University of Medicine and Dentistry of New Jersey.
Eileen Sullivan-Marx, PhD, RN, FAAN, is the dean of the New York University Rory Meyers College of Nursing and the Erline Perkins McGriff Professor of Nursing. She is a distinguished nursing leader, educator, and clinician known for research and innovative approaches in primary care, testing methods of payment for nurses particularly with Medicaid and Medicare, sustaining models of care using advanced practice nurses locally and globally, and developing health policy in community-based settings. With a strong belief in the integration of practice, research, education, and interdisciplinary team work, Sullivan-Marx has built and sustained models of team care including a private family practice, growing a Program of All Inclusive Care for Elders (PACE) from 75 to 525 people in five years that saved the state of Pennsylvania fifteen cents on the dollar in Medicaid funding, and launched numerous older adult team programs in academic centers as well as the Veterans Administration. Sullivan-Marx will serve as the president of the American Academy of Nursing from October 2019 through October 2021. She is active in regional, state, and national policy, and served as an American Political Science Congressional Fellow and Senior Advisor to the Center for Medicare & Medicaid Services Office of Medicaid and Medicare Coordination in 2010, just after the passage of the Affordable Care Act.
Emily Frye is Director for Cyber Integration at the Homeland Security Center at The MITRE Corporation. She is an expert on homeland security, critical infrastructure and cybersecurity. Frye’s work has helped define and explore options for the future of comprehensive, nationwide cybersecurity approaches across both public and private sectors, bridge the divide between federal and state government on cybersecurity initiatives, and strengthen public-private partnerships in support of critical infrastructure security and resilience. Frye has served on both the Long-Range Planning Committee for the Section of Science & Technology of the American Bar Association, and as advisor to the Diversity Committee of the American Bar Association. She is an accomplished speaker and moderator, and has written about issues relating to critical infrastructure, national resilience, digital technology, national security, privacy, economic impacts of cybersecurity, and the role of insurance in Critical Infrastructure Protection. She received her Doctor of Jurisprudence degree from George Mason University and her undergraduate degree from William & Mary. Her speaking appearances include a cybersecurity conference hosted by the Atlantic Council in Poland and Xconomy’s Cyber Madness. She has also written in The Hill on the need for an international cyber court, and been quoted by Slate and CybersecurityTV.
Dr. Eric Bernicker is board certified by the American Board of Internal Medicine in medical oncology. He completed his medical training, a residency in internal medicine, and a fellowship in hematology at Baylor College of Medicine. He also completed a fellowship in medical oncology at MD Anderson Cancer Center. Bernicker is the primary investigator for a number of clinical trials looking at different novel therapies for lung cancer, including immunotherapy. His main clinical focus is on solid tumor oncology, specifically cancers that arise in the thorax such as lung cancer, mesothelioma, head, and neck cancer, and uveal melanomas. He is also interested in targeted therapy for specific mutations that can lead to more personalized treatments for patients battling cancer. He is a member of the American Society of Clinical Oncology, the American Association for Cancer Research, and the International Association for the Study of Lung Cancer.
Erica Ollmann Saphire, Ph.D. is a Professor of the La Jolla Institute for Immunology and one of the world’s leading experts in pandemic and emerging viruses, such as Ebola, Marburg and Lassa. Dr. Saphire directs the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC), an NIH-funded Center of Excellence in Translational Research. The VIC unites 43 previously competing academic, industrial and government labs across five continents to understand which antibodies are most effective in patients and to streamline the research pipeline to provide antibody therapeutics against Ebola, Marburg, Lassa and other viruses. Dr. Saphire's research explains, at the molecular level, how and why viruses like Ebola and Lassa are pathogenic and provides the roadmap for developing antibody-based treatments. Her team has solved the structures of the Ebola, Sudan, Marburg, Bundibugyo and Lassa virus glycoproteins, explained how they remodel these structures as they drive themselves into cells, how their proteins suppress immune function and where human antibodies can defeat these viruses. A recent discovery revealed why neutralizing antibodies had been so difficult to elicit against Lassa virus, and provided not only the templates for the needed vaccine, but the molecule itself: a Lassa surface glycoprotein engineered to remain in the right conformation to inspire the needed antibody response. This molecule is the basis for international vaccine efforts against Lassa. Dr. Saphire is the recipient of numerous accolades and grants, including the Presidential Early Career Award in Science and Engineering presented by President Obama at the White House; the Gallo Award for Scientific Excellence and Leadership from the Global Virus Network; young investigator awards from the International Congress of Antiviral Research, the American Society for Microbiology, American Society for Biochemistry and Molecular Biology, and the MRC Centre for Virus Research in the United Kingdom; the Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, and the Surhain Sidhu award for the most outstanding contribution to the field of diffraction by a person within five years of the Ph.D. Dr. Saphire has been awarded a Fulbright Global Scholar fellowship from the United States Department of State and a Mercator Fellowship from the German research foundation, Deutsche Forschungsgemeinschaft, to develop international collaborations around human health and molecular imaging through cryoelectron microscopy. Dr. Saphire received a B.A. in biochemistry and cell biology and ecology and evolutionary biology from Rice University in Houston, Texas, and a Ph.D. in molecular biology from Scripps Research. She stayed on at Scripps Research as a Research Associate to conduct postdoctoral research and rose through the ranks to become a Professor in the Department of Immunology and Microbiology. In early 2019, Dr. Saphire joined La Jolla Institute for Immunology to establish a molecular imaging facility for cryo-electron microscopy (cryo-EM) at the Institute. The extremely detailed images produced by cryo-EM reveal precisely how essential mechanisms of the immune system operate.
Breast cancer early detection, mammography/breast imaging, breast biopsy, breast cancer screening, radiology
Cancer, Breast Cancer Screening, Radiology, Mammography, breast cancer early detection, Breast Cancer, Breast Imaging, breast biopsy
Ernest Goss is the Jack MacAllister Chair in Regional Economics at Creighton University and served as the initial director for Creighton’s Institute for Economic Inquiry. He is also principal of the Goss Institute in Denver, Colo. Goss received his Ph.D. in economics from The University of Tennessee in 1983 and is a former faculty research fellow at NASA’s Marshall Space Flight Center. He was a visiting scholar with the Congressional Budget Office for 2003-2004, and has testified before the U.S. Congress, the Kansas Legislature, and the Nebraska Legislature. In the fall of 2005, the Nebraska Attorney General appointed Goss to head a task force examining gasoline pricing in the state.
Associate Professor, VCU School of Pharmacy
Diabetes education and self-management, drug therapy, heart health
Diabetes, Diabetes & Endocrinology, Diabetes Alert Day, Diabetes and Adults, Type 1 Diabetes, Type Diabetes, Type 2 Diabetes Mellitus, Diabetes Medications, Diabetes Drugs
Professor & Director - Stem Cell Regenerative Med.
Neural stem cell function; regenerative medicine and neurodegenerative diseases
Stem Cells, Spinal Cord Injury, Parkinson's Disease, ALS, Bipolar Disorder
Former First Lady Nancy Reagan said NO to drugs but YES to stem cell research. Where are we now? @sbpdiscovery researcher explains.
Hot cars, Water Safety, Drowning, distracted driving, Holiday toy safety
Beaches, lakes, and pools are great ways to beat the heat but there are precautions to take before reaching for that swimsuit, said Gabriella Cardone, MD, an emergency medicine pediatrician with McGovern Medical School at UTHealth and attending physician at Children’s Memorial Hermann Hospital. “Taking the time to follow some basic precautions will keep you and your loved ones safe in the water all summer long,” Cardone said. Before engaging in aquatic activities, make sure everyone knows how to swim or has an approved life jacket. Water noodles, inner tubes, or water wings do not count. Tragically, there are approximately 3,536 fatal unintentional drownings in the U.S. every year, which is an average of 10 deaths a day, according to the Centers for Disease Control and Prevention. “Children should learn how to swim by age 4 and their parents should learn cardiopulmonary resuscitation or CPR in case of emergency,” Cardone said.
Practicing internal medicine physician who has served as chairman and CEO of the Virginia Mason Health System in Seattle since 2000. He is also chair of the National Patient Safety Foundation Lucian Leape Institute and immediate past chair of the Institute for Healthcare Improvement Board of Directors. During his tenure as chief executive, Virginia Mason has become a national leader in quality, safety and innovation resulting from its Toyota Production System-inspired lean management methodology, the Virginia Mason Production System. To schedule an interview with Dr. Kaplan, contact Virginia Mason Media Relations.
Dr. Kumar provides comprehensive care to children, adolescents and young adults. His special areas of interest include asthma, attention deficit hyperactivity disorder (ADHD) and obesity.
Pediatrics, Pediatrician, Sinai Hospital, Lifebridge Health, Adolescent Medicine, young adult medicine, Asthma, Attention Deficit Hyperactivity Disorder, ADHD, Bullying
Dr. Kumar is a board-certified pediatrician with nearly 20 years of experience. He earned his Doctor of Medicine degree from Johns Hopkins University School of Medicine, where he also completed his internship and residency in pediatrics. Dr. Kumar is a fellow of the American Academy of Pediatrics and is active in the Maryland chapter of the organization.
Harvinder Gill is a graduate advisor, associate professor and Whitacre Endowed Chair of Science and Engineering in the Department of Chemical Engineering within the Texas Tech University Edward E. Whitacre Jr. College of Engineering. He directs the Gil Lab where he and his colleagues perform fundamental and translational research in the fields of drug delivery, vaccines, immunotherapy, and nanomedicine to help address some of the pressing biomedical challenges facing human health. His research integrates the knowledge and tools from various disciplines including engineering, chemistry, biology, immunology, recombinant engineering, and micro-nano-technology. Gill currently works to discover innovative drug and vaccine delivery platforms aimed at maximizing stimulation of mucosal immunity in order to address the challenges related to influenza and HIV infectious diseases as well as developing a delivery system for localized delivery of cancer drugs directly into oral tumors. Dr. Gill also is working on developing a delivery method to eliminate peanut allergies through a grant from the NIH, working to transform pollen grain shells into vehicles for delivery of allergy vaccines, and using microneedles to eliminate the need for regular needles to deliver vaccines. Gill earned his bachelor's degree in chemical engineering from Panjab University in 1994 and his doctorate in bioengineering from the Georgia Institute of Technology in 2007.
Heidi is conducting health-related research in the following areas: 1) implementing and evaluating a comprehensive campus suicide prevention program; 2) facilitating mental health treatment-seeking in military personnel.
Trauma, Mental Health, Anxiety, Stress, Sexual Violence, Suicide, Posttraumatic Stress Disorder, Depression, Military personnel, service use, Intervention
URI’s Isaac Ginis uses computer model to predict the power of storms. The 2019 hurricane season officially kicked off June 1. Predicting the severity of a hurricane can mean the difference between life and death. URI Professor of Oceanography Isaac Ginis makes it his business to predict the power of these ferocious storms with a computer model so successful it was adopted by the National Weather Service. Ginis’s research efforts have resulted in pioneering advances in modeling of the tropical cyclone-ocean interactions that have led to significant improvements in hurricane intensity forecast skills. Ginis’s research group has contributed to the development of the HWRF hurricane model used by the U.S. National Hurricane Center and Joint Typhoon Warning Center for operational forecasting of tropical cyclones in all ocean basins. He is currently leading a project funded by the U.S. Department of Homeland Security Coastal Resilience Center of Excellence to develop advanced modeling capabilities for more accurate representation of hurricane hazards and impacts in Southern New England. This project allows DHS and other agencies to better understand the consequences of coastal and inland hazards associated with extreme hurricanes and Nor’easters and to better prepare coastal communities for future risks.
Isaac Yang, M.D., is a nationally renowned neurosurgeon specializing in brain tumors, superior semicircular canal dehiscence (SSCD), and skull base brain surgery at UCLA. Yang is a board-certified neurosurgeon and director of medical student education for the UCLA Department of Neurosurgery; an associate professor of neurosurgery, head and neck surgery, and radiation oncology at the David Geffen School of Medicine at UCLA, and a principal investigator at the UCLA brain tumor laboratory. Yang is highly sought out by peers, patients and the media for his expertise in neurological diseases and brain health. He has made multiple TV appearances on Good Morning America, CBS' The Doctors, Dr. Drew LifeChangers, and several national news outlets. Originally from Lodi, Calif., Yang developed an interest in neurobiology as an undergraduate. He earned his bachelor’s degree with Phi Beta Kappa from the University of California, Berkeley. His training followed with a medical degree from the David Geffen School of Medicine at UCLA. Yang completed a neurological surgery residency at the University of California San Francisco, as well as an NRSA NIH-funded F32 postdoctoral brain tumor research fellowship. Yang’s clinical focus has been primarily on brain tumors, both glioblastoma and skull base tumors. His research efforts have examined antigen expression and manipulation of the immune response to glioblastoma. His work was recognized by a UCSF Clinical and Translational Scientist Training Award and the CNS Dandy Clinical Research Fellowship. Yang has been the recipient of several distinguished regional and national awards, including the UCSF Medical Center 2010 Exceptional Physician Award, the AANS Integra Brain Tumor Research Award, San Francisco Neurological Society Edwin Boldrey Award for Basic Science Research, American Academy of Neurological and Orthopedic Surgeons Research Award, Kaiser Award for Clinical Research, the national AANS Leksell Radiosurgery Award, and the Tumor Section Ronald L. Bittner Award on Brain Tumor Research. Yang has published more than 150 publications in peer-reviewed journals and authored more than half a dozen book chapters. At UCLA, he is investigating the use of nanoparticles and nanotechnology for their application in brain tumor immunotherapy and vaccines. Dr. Isaac Yang is dedicated to improving the care and treatment of all patients undergoing neurosurgery. If interested please follow Dr. Yang on Facebook at Isaac Yang UCLA Neurosurgery or find his most recent book, Service Minded Physician, on Amazon.
Dr. Campbell is an expert in domestic violence, intimate partner violence, homicide by intimate partners, health effects of violence on women and children, traumatic brain injury, and prevention of violence.
Domestic Violence, intimate partner abuse, Intimate Partner Violence, Homicide, intimate partner homicide, Health Outcomes, Research, Nurse, Johns Hopkins, Nursing, Pregnancies, Women's Health, Gun Control, Gun Control Laws, Abuse & Trauma, abuse preventio
Jacquelyn Campbell is a national leader in research and advocacy in the field of domestic violence or intimate partner violence (IPV). Her expertise is frequently sought by national and international policy makers in exploring IPV and its health effects on families and communities. Her most recent research in health sequelae has been foundational for the areas of the intersection of HIV and violence against women and how head injuries and strangulation from intimate partner violence can result in undiagnosed and untreated Traumatic Brain Injury. She has consistently advocated for addressing health inequities of marginalized women in this country and globally affected by experiences of violence. She has served as Principle Investigator on 14 federally funded collaborative research investigations through the National Institutes of Health, National Institutes of Justice, Department of Defense, the Department of Justice (Office of Violence Against Women), and Centers for Disease Control to examine intimate partner homicide and other forms of violence against women as well as interventions and policy initiatives to improve the justice and health care system response. This work has paved the way for a growing body of interdisciplinary knowledge about experiences of violence and health outcomes, risk assessment for lethal and near-lethal domestic violence, and coordinated system (justice, social services, and health) responses to address intimate partner violence. Dr. Campbell has published more than 270 articles, 56 book chapters and seven books, in addition to developing the Danger Assessment, an instrument to assist abused women in accurately determining their level of danger. The Danger Assessment is also the basis of the Lethality Assessment Program (MNADV LAP) for first responders to assess risk of homicide of domestic violence survivors and connect those at high risk with domestic violence services. In collaboration with Dr. Nancy Glass, originator of myPlan, a decision aid for IPV survivors, she is leading an NIH-funded cultural adaptation of myPlan for immigrant and indigenous women. Elected to the Institute of Medicine in 2000, Dr. Campbell also was the Institute of Medicine/American Academy of Nursing/American Nurses' Foundation Senior Scholar in Residence and was founding co-chair of the IOM Forum on the Prevention of Global Violence. Other honors include the Pathfinder Distinguished Researcher by the Friends of the National Institute of Health National Institute for Nursing Research, Outstanding Alumna and Distinguished Contributions to Nursing Science Awards, Duke University School of Nursing, the American Society of Criminology Vollmer Award, and being named one of the inaugural 17 Gilman Scholars at Johns Hopkins University. She is on the Board of Directors for Futures Without Violence, is an active member of the Johns Hopkins Women’s Health Research Group, and has served on the boards of the House of Ruth Battered Women's Shelter and four other shelters. She was a member of the congressionally appointed U.S. Department of Defense Task Force on Domestic Violence.
James Hendler, the Director of the Institute for Data Exploration and Applications (IDEA) at Rensselaer Polytechnic Institute is an expert in artificial intelligence and one of the originators of the “Semantic Web.” Hendler currently serves as the chair of the U.S. Technology Policy Committee for the Association of Computing Machinery (ACM) which includes subcommittees on voting and cybersecurity. He is a former member of the U.S. Air Force Science Advisory Board, the former chief scientist of the Information Systems Office at the U.S. Defense Advanced Research Projects Agency (DARPA), and a recipient of the U.S. Air Force Exceptional Civilian Service Medal. In addition to numerous other policymakers and government agencies, including the Department of Defense, Hendler has worked with the White House on the development of Data.gov, the U.S. government’s open data site, as an “Internet Web Expert.” In 2010, Hendler was named one of the 20 most innovative professors in America by Playboy magazine
James L. Frazier III
Chief, Neurosurgery, Northwest Hospital
Neck and arm pain, low back and leg pain, lumbar stenosis, minimally invasive spine techniques, non-surgical spine care spinal cord stimulation, spinal tumor ablation, spine tumors spine trauma, cervical conditions
Neck Pain, arm pain, Low Back Pain, Leg Pain, Lumbar Stenosis, non-surgical spine care, Spinal Cord Stimulation, spinal tumor ablation, Spine Tumors, Spine trauma, cervical conditions
Dr. Frazier completed a neurosurgical residency at the Johns Hopkins Hospital after earning a medical degree from the Johns Hopkins University School of Medicine and an undergraduate degree magna cum laude from Brown University in Providence, Rhode Island. As a medical student, Dr. Frazier received the Hunterian Medical Student Research Award for his work on interstitial chemotherapy for brain tumors. During his training, Dr. Frazier completed specialized fellowships in neuro-oncology and radiosurgery.
Director of Strategy, Global Security Initiative
Data privacy, cybersecurity, internet, FCC regulations, communications, and defense.
Data Privacy, Cybersecurity, Defense, Defense Advanced Research Projects Agency (DARPA), Internet, FCC, Regulations, Government, National Security
Researchers available to discuss user privacy, diversity, the dark web, data breaches, hacking, robocalls and more during Cybersecurity Awareness Month
A former EPA administrator is available to comment on the lawsuit filed over the Trump Administration's attempts to ease restrictions on coal burning power plants under the Clean Power Plan
Dr. Patterson’s laboratory works on the development of countermeasures against potential biological weapons. Her group focuses on the development of therapies and vaccines against naturally occurring pathogens that can cause sporadic but lethal outbreaks, and her most recent studies concentrate on hemorrhagic fever viruses. Dr. Patterson has been involved in the development of three vaccines against Ebola and two vaccines against Lassa fever that are undergoing further studies. Her lab utilizes the maximum containment laboratory (BSL-4) at Texas Biomed. Dr. Patterson helped develop a marmoset model used for multiple infectious agents: Ebola virus Marburg virus Lassa fever Eastern Equine Encephalitis virus
Jeff Greeson, PhD, is a Fellow at the Institute for Integrative Health and an Assistant Professor of Psychology at Rowan University in New Jersey. He received his B.A. in Psychology from Swarthmore College, a Masters in Biomedical Chemistry from Thomas Jefferson University, and his Ph.D. in Clinical Psychology from the University of Miami. He completed his clinical internship and postdoctoral fellowship at Duke University Medical Center and was on the faculty at Duke from 2006-2014. Prior to joining Rowan, Dr. Greeson served as Assistant Professor in Clinical Psychology at the University of Pennsylvania, Perelman School of Medicine. Through the Institute for Integrative Health, Greeson is conducting research to understand how mindfulness, as a self-care practice, can reduce the risk of stress-related illness and promote integrative health. A small handful of recent clinical studies have shown that mindfulness meditation can modify gene expression in immune cells, opening the door to a new field of scientific inquiry that Greeson calls “mindfulomics.” This new field, however, is complicated by the fact that mindfulness is at once a state, a trait, and a skill that one can develop through practice, like meditation or yoga. Therefore, to advance our understanding of the impact of mindfulness at the level of biology and our genes, Greeson is examining the following research questions: 1. What pattern of genes are engaged in state mindfulness, when people meditate compared to when they are stressed or just resting quietly? 2. What pattern of genes corresponds to "high" vs. "low" levels of trait mindfulness, measured by scores on a standardized questionnaire? 3. What combination of genes are engaged in a successful treatment response to mindfulness training, and does this genetic pattern correlate to health outcomes, such as psychological well-being, sleep, and objective health measures like blood pressure and inflammation? To view Greeson’s published research articles, please visit: https://www.ncbi.nlm.nih.gov/pubmed/?term=jeffrey+greeson. https://www.researchwithnj.com/en/persons/jeffrey-greeson/publications/ https://scholar.google.com/citations?user=DTEwIR8AAAAJ&hl=en&oi=ao
McCune has written widely on issues relating to masculinity, particularly black masculinity, as well as queer studies, sexuality theory, critical race theory, performance studies and popular culture. His book, “Sexual Discretion: Black Masculinity and the Politics of Passing” (University of Chicago Press, 2014), examines the lives of African-American men who have sex with men while maintaining a heterosexual lifestyle in public.
Jeffrey Shaman, PhD, MS, is the Chief Science Officer at Coriell Life Sciences where he oversees the company’s research, education, and clinical programs and leads efforts focused on bridging the gap between genetic science and clinical application. Dr. Shaman brings years of experience in advising cross-functional teams together with his scholarship in genetics, pharmacology, stem cells, and clinical laboratory operations. Along with the CEO, he forges strategic partnerships with worldwide companies, laboratories, academic institutions, public/private self-insured companies, and federal, state, and regional healthcare and employee systems. Dr. Shaman supports a team of scientists dedicated to precision medicine and who actively research, publish, and present findings in top-tier peer-reviewed journals. He is passionate about educating people from all backgrounds about the power of genetics and pharmacogenomic testing that is integrated with patient health history and clinical decision-support to proactively promote better health. Dr. Shaman holds a doctoral degree from The Johns Hopkins University School of Medicine in Pharmacology and Molecular Sciences, where his research centered on DNA, epigenetics, and nuclear structure and function. He earned his Master of Science degree from The University of Medicine and Dentistry of New Jersey in Cell & Developmental Biology. Dr. Shaman held a faculty position at the University of Hawai‘i Institute of Biogenesis Research before serving a fellowship at Harvard Medical School and implementing a translational research program at Beth Israel Deaconess Medical Center and the Bedford Stem Cell Research Foundation.
Professor of Medicine in the Division of Infectiou
Sexually transmitted diseases, HIV/AIDS, Cryptococcus, digital technology, global health, travel medicine, public health
Sexually Transmitted Disease, STI, HIV, AIDS, Public Health, Global Health, Infectious Disease
Dr. Jeffrey Klausner is an expert in infectious disease prevention and control. He is a frequent advisor to the Centers for Disease Control and Prevention and the World Health Organization (WHO). From 1998-2009, Klausner was a deputy health officer, director of STD prevention and control services at the San Francisco Department of Public Health and from 2009-2011 was branch chief for HIV and TB at the Centers for Disease Control, South Africa. Dr. Klausner research interests are in applied epidemiology and the prevention and control of infectious diseases of public health importance like HIV, STDs, TB and cryptococcus. Dr. Klausner has a particular interest in the use of technology—information, digital, and laboratory—to facilitate access to treatment for disadvantaged populations. Dr. Klausner has been funded by the NIH, CDC, private pharmaceutical and test manufacturers to study the benefits of new ways to find and treat infectious diseases. He has been a leading advocate in the use of medical male circumcision for HIV and STD prevention.
I balance cutting-edge fieldwork with analysis of global ecological data to examine how human changes to fire patterns are encouraging forest-savanna transitions, degrading ecosystems and increasing greenhouse gas emissions. Together with an international community of collaborators, I work across disciplines and scales—from individual organisms to entire ecosystems.
Assistant Professor of Anthropology
Latino immigrant farmworkers, driver's licenses, medical plurality, Chile.
Immigrant Farmworkers, Migrant Farm Workers, Driver's Licenses, immigrant communities, Immigrant Families, Medical Communication, medical plurality, Chile
Professor Guzmán is a linguistic and medical anthropologist. Her present research focuses on how Latinx immigrant farmworkers in New York talk about mobility, vulnerability, and well-being. Guzmán has also conducted research on medical interaction in Chile and the United States.
Chang's work focuses on the therapy resistance of cancer stem cells, which has led to several publications and international presentations. Her clinical research aims to evaluate novel biologic agents in breast cancer patients. Chang has worked in the field of tumor-initiating cells for more than 10 years. After her discovery that tumor-initiating cells are chemo-resistant, and that targeting the EGFR/HER2 pathway can decrease this subpopulation, Chang played a key role in demonstrating some of the limitations and mechanisms of tumor-initiating cells. Her work is now focused on the mechanisms that regulate TICs, as well as initiating and planning clinical trials that target this critical tumor initiating subpopulation. She is also interested in characterizing the cross-talk between these different pathways that may lead to mechanisms of resistance, and has identified some of the chief regulatory pathways involved in TIC self-renewal. She is a world-renown clinical investigator, credited as one of the first to describe intrinsic chemo-resistance of tumor-initiating cells.
My research is centered on understanding and explaining how people make conservation-related judgments and decisions, and the intersection of such judgments with conservation policy. I am particularly interested in how people make decisions related to the conservation of wildlife, and the origins of resource-related conflicts, especially those that involve wildlife. Much of my recent work is focused on understanding judgments and behaviors concerning large carnivores. Natural resources-related values, attitudes, behaviors Natural resources conflicts Wildlife management and policy Human-wildlife conflict
Lecturer, Dept of Political Science and Internatio
Post-conflict political reconstruction and the political rights of refugees. Worked in multitudes of war-torn countries to help facilitate their election process post-conflict. Democratization and refugee protection.
Democratization, Refugee, Refugee Protection, Post-conflict elections
Jeremy Grace has been a member of the Geneseo faculty since 2000. He is also the coordinator of the International Relations program. He is a lecturer of international relations and director of the IR program at SUNY Geneseo. He received his M.A in International Affairs from American University in Washington DC in 1995. Prior to joining the Geneseo faculty in 2000, he worked for four years designing democratization and elections programs with the Organization for Security and Cooperation in Europe (OSCE) and International Organization for Migration (IOM) in Bosnia and Herzegovina, Kosovo, and East Timor. He has published studies and discussion papers for the IOM, IFES, and the World Bank, and served as Senior Advisor to the IOM Political Rights and Enfranchisement System Strenthening project aimed at protecting the political rights of refugees and conflict-forced migrants. As part of the project, he has provided technical assistance related to peacebuilding, refugees, and democratization to national governments and international organizations through field assessments to Kosovo, Liberia, Uganda, Nepal, and Afghanistan, among others.
Professor & Senior VP- Neuroscience Drug Discovery
Genomic mosaicism; Brain development, Alzheimer's disease and drug discovery
Neuroscience, Alzheimer's Disease, Multiple Sclerosis (MS), Parkinson's Disease
Professor of medicine at Georgetown University Medical Center. A member of the Institute of Medicine, Goodman is trained in infectious diseases and public health. He formerly served as the U.S. Food and Drug Administration Chief Scientist and Deputy Commissioner. He worked extensively on emerging infectious diseases at FDA and with the U.S. Department of Health and Human Services and has served as an advisor to the World Health Organization and others on medical countermeasures and vaccines. Goodman is director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) at Georgetown and a clinician at MedStar Georgetown University Hospital, the Washington D.C. VA Medical Center and Walter Reed National Military Medical Center.
Jill Heinrich is a Professor of Education. She taught high school English for eleven years, and her research interests include religious literacy and separation of church and state in American public education, masculinity studies, comparative education in Belize, and poverty and education. Heinrich teaches an off-campus course in San Pedro Town on the island of Ambergris Caye in the country of Belize.
Joanne Turner, Ph.D., is the Vice President for Research at Texas Biomedical Research Institute. In addition to her administrative role, where she oversees the research functions of Texas Biomed, she also manages a research program. Her research focuses on immunology of Mycobacterium tuberculosis infection and immunology of aging. More specifically, she studies the changes that take place in the immune system during the natural aging process and how those changes can influence both innate and adaptive immune function when infected with M. tuberculosis. She also studies immune responses that correlate with an individual’s susceptibility to reactivate a previously latent infection with M. tuberculosis. Dr. Turner received her Ph.D. in Immunology from the London School of Hygiene and Tropical Medicine. She started with Texas Biomed this past summer, having previously served as a Professor and Biosafety Level 3 Program Director at The Ohio State University.
Jodi A. Mindell, Ph.D., is a Professor of Psychology and Director of Graduate Psychology at Saint Joseph's University. She is a clinical psychologist specializing in pediatric sleep medicine. Dr. Mindell has written extensively on pediatric sleep disorders and presented over 350 papers at national and international conferences. Her research focuses on assessment and treatment of infant and toddler sleep disturbances, cross-cultural differences in sleep in young children, and the impact of sleep on development. She is the chair of the Pediatric Sleep Council (BabySleep.com) and author of Sleeping Through the Night: How Infants, Toddlers, and Their Parents Can Get a Good Night's Sleep (HarperCollins).
URI Professor Joëlle Rollo-Koster: Medieval historian, papacy expert Key topics: French culture, medieval history, the papacy, Game of Thrones URI Professor Joëlle Rollo-Koster is a leading historian on the papacy. A professor of medieval history at URI, she is leading an international team compiling a complete history of the papacy for Cambridge University Press. She is the author of eight books on medieval history and the papacy. Koster was knighted by the French government with the medal of the Chevalier des Palmes académiques in 2016. A native of France, Koster recently shared her insights on the impact of the 2019 fire at the Notre-Dame Cathedral in Paris with numerous media outlets. A professor, at URI, Koster incorporates the popular Game of Thrones series into her curriculum. She was featured in a Time.com story (4/25/19), discussing the history of medieval knights after the character Brienne, from Game of Thrones, was knighted — a true milestone for fans of the hit series. Joëlle Rollo-Koster received her undergraduate degree and master's degree in history from the University of Nice, France. She earned a Ph.D. in History at SUNY Binghamton in 1992. Select authored publications: -Raiding Saint Peter: Empty Sees, Violence, and the Initiation of the Great Western Schism (1378), 2008, Brill, ISBN 9789047433118 -The People of Curial Avignon: A Critical Edition of the Liber Divisionis and the Matriculae of Notre Dame la Majour, 2009, Edwin Mellen Press, ISBN 077344680X -Avignon and Its Papacy, 1309–1417: Popes, Institutions, and Society, 2015, Rowman and Littlefield, ISBN 9781442215320 -Death in Medieval Europe: Death Scripted and Death Choreographed, Routledge, 2016, ISBN 9781138802131
Dr. Bernal oversees all aspects of the SNPRC animal care and use program. He has more than 36 years of experience in laboratory animal care and medicine. To increase the number of certified laboratory animal technicians at Texas Biomed and other institutions, he has developed institution-wide training and certification programs. Dr. Bernal has been integral to developing the SNPRC study process manual that details all of the steps required to complete a study from start to finish. Dr. Bernal oversees and develops standard operating procedures for: Comprehensive socialization and environmental enrichment plan Preventative medicine program (frequent physicals, TB testing, parasite evaluation, viral testing) Veterinary care program Aseptic technique Management of pain and distress Animal enclosure sanitation.
Family Medicine - tobacco cessation, alternative tobacco products, e-cigarettes, environmental toxins, second-hand smoke
Family Medicine, Ambulatory Medicine , Health Promotion and Disease Prevention , Health Promotion, Disease Prevention, Cancer Prevention, Tobacco Cessation, Osteoporosis, Tobacco, Diabetes
Spangler is one of the world's leading experts in tobacco epidemiology and was the keynote speaker for 2004 World Health Organization Tobacco and Community Health Conference in New Delhi, India. He founded the first physician-run tobacco-cessation clinic in North Carolina and was recently awarded $1.6 million grant to develop tobacco cessation curriculum for medical schools across the United States. He has won several prestigious awards including the Association of Teachers of Preventative Medicine Program of the Year Award and the Behavioral Sciences Forum Program of the Year Award. He is currently co-Principal Investigator on a longitudinal study of tobacco use among students at 11 colleges and universities in NC and VA.
I have been working at the VA Medical Center and in the Department of Behavioral Neuroscience at the Oregon Health & Science University in Portland since 1979. I entered graduate school at the University of Colorado to obtain a Ph.D. in social psychology. Fortuitously, I was sidetracked into instead studying behavioral neuroscience (AKA biopsychology) at the fledgling Institute for Behavioral Genetics in Boulder. I’ve been pretty much surrounded by mice ever since. I did post-doctoral work at the University of Wisconsin- Milwaukee and was a Lecturer in Psychology at San José State and then UC-Santa Barbara, and then held a two-year research position at a Dutch pharmaceutical company in the Dutch hinterlands before Portland. My research interest is in understanding individual differences in behavioral susceptibility to alcohol and other drugs of abuse, and their genetic and neurobiological bases. Most recently, I’ve been breeding mice that voluntarily drink alcohol until they become intoxicated, i.e. developing a mouse model of university students. I’m working with collaborators to figure out how many genes we’ve affected in the process, which ones they are, and what their biological functions are. We’re using that information to try to predict some drugs that are already FDA approved that might be re-purposed to try as treatments for alcoholism. My expertise is in mouse behavioral tests that try to capture human traits such as anxiety, sensitivity to drug’s rewarding or aversive effects, incoordination, learning and memory, novelty-seeking, and so forth. I am less fluent in rat than in mouse but the languages are related. I am familiar with psychiatric genetics/human genetics methods, but not really expert in the more esoteric of them. I am also familiar with the big data/genomics/informatics approaches, but again not really expert there, either.
Senior advisor for global health to Georgetown University President John J DeGioia; senior fellow, McCourt School of Public Policy; and senior scholar, O’Neill Institute for National and Global Health Law. Monahan served as the special advisor for Global Health Partnerships at the US Department of State (2010-2014) as well as a counselor to the secretary and director of global health affairs at the U.S. Department of Health and Human Services (2009-2010). While at HHS, Monahan served as the U.S. Government’s primary contact with the leadership of the World Health Organization during the 2009 H1N1 pandemic and helped coordinate the U.S.-led diplomatic strategy to secure commitments from developed countries for donating influenza vaccines to low-income countries. Monahan can discuss the obligation of WHO and member states to support and respond to disease outbreaks.
fellowship-trained Board Certified orthopedic spor
Orthopedic Surgery, Orthopaedic Sports Medicine Areas Of Interest: Knee Injuries, i.e. ACL Tears, Meniscal Tears, Cartilage Injuries; Shoulder Instability, SLAP Tears, Biceps Tendonitis; Rotator Cuff Injuries, Elbow Ulnar Collateral Ligament Injury, etc
Orthopedic Sports Medicine, Orthopedic Surgery, Sports Medicine, Sport
John-Paul Rue, M.D., is a fellowship-trained Board Certified orthopedic sports medicine surgeon, specializing in arthroscopic repair of sports-related injuries, including complex knee and shoulder reconstructions with Orthopedics and Joint Replacement at Mercy. Dr. John-Paul Rue specializes in the prevention and treatment of injuries related to sports and exercise. He treats patients of all ages, serving athletes ranging from the casual jogger or weekend warrior to competitive and collegiate athletes and beyond. His primary focus is treating injuries of the knee, shoulder, and elbow, from ACL tears, meniscus and cartilage injuries to shoulder instability and rotator cuff injuries. He also sees patients with injuries such as overuse tendonitis, ankle sprains, and fractures. As an orthopedic surgeon and sports medicine specialist, Dr. Rue is able to diagnose and treat a wide variety of acute and overuse injuries utilizing both surgical and non-operative techniques. He works closely with colleagues and rehabilitation specialists to guide patients through the recovery process, recommend related strength and conditioning exercises and offer return-to-play insight and guidelines. Dr. Rue’s patient-centered approach to treatment and rehabilitation allows him to develop strong doctor-patient relationships and personalized treatment plans for each patient. He is committed to helping his patients perform at their very best when participating in their chosen sports and physical activities. Dr. Rue is a graduate of the United States Naval Academy and served as the head team physician for the Naval Academy before coming to Mercy. He deployed to Iraq with the 1st Marine Expeditionary Force in support of Operation Iraqi Freedom as the Chief Orthopedic Surgeon, Charlie Surgical Company Forward Resuscitative Unit, Camp Fallujah, Iraq and continues his commitment to service as a Naval Reservist. As a respected sports medicine physician, Dr. Rue has contributed numerous print and online publications highlighting his research and experience in the field of orthopedic sports medicine and has given invited lectures on a variety of orthopedic conditions at national and international scientific meetings. His research has garnered 2 major awards from the American Orthopedic Society for Sports Medicine. He is a member of multiple notable medical associations and serves as an expert scientific reviewer for several medical journals, including the American Journal of Sports Medicine, and The Journal of Knee Surgery.
Losos is an internationally renowned scholar in the field of evolutionary biology. In partnership with the Missouri Botanical Garden and the St. Louis Zoo, Losos leads the Living Earth Collaborative, an academic center dedicated to advancing the study of biodiversity. The Living Earth Collaborative serves as a hub to facilitate interdisciplinary research among plant and animal biologists and other scholars across a wide range of fields, bringing together the world’s leading scholars in the field of biodiversity to address the most pressing issue facing humankind today — the ability to sustain life on Earth.
Dr. Torrelles’ research is focused on the study of the human lung environment and its effect on the outcome of TB disease due to Mycobacterium tuberculosis (M.tb) infection. He also aims to improve the diagnosis of susceptible and drug resistant TB in high burden areas. Beyond the diagnosis of TB, Dr. Torrelles and his team aim to understand the impact of the human lung mucosa in TB pathogenesis. He and his team have found that there are enzymes in the human lung mucosa that modify the bacteria prior to infecting host cells, thus, potentially redefining the M.tb pathway of infection and disease outcome. Dr. Torrelles is originally from Catalonia, Spain. He received his Ph.D. in biochemistry/ microbiology in 2003 from the Autonomous University of Barcelona. During his graduate studies, he moved to Fort Collins, Colorado to serve as a visiting scientist at Colorado State University. He finished his Ph.D. and became a research associate and lab manager before moving to The Ohio State University for his postdoctoral fellowship, where over the years he became independent and obtained the appointment of tenured Associate Professor.
Joseph McCleery, Ph.D. is an assistant professor in the Department of Psychology, and Executive Director of Academic Programs in the Kinney Center for Autism Education and Support, at Saint Joseph's University. His research is focused along three major themes. The first theme involves examining and elucidating the mechanisms of social processing and perception in infants, children, and adults with and without Autism Spectrum Disorder (ASD). The second theme concerns the examination of genetic impacts on brain functioning, through the study of the relationships of normal genetic variation and rare genetic syndromes (e.g., mutations, microdeletions) with brain and behavioral functioning. The third theme involves the evaluation and development of behavioral and cognitive-behavioral interventions for individuals with ASD. Dr. McCleery has published his research and ideas in leading peer-reviewed journals in the fields of Clinical Psychology, Psychiatry, and Neuroscience and his research has been supported by a number of organizations.
Joseph J. Ciotola, M.D., is a top rated orthopedic surgeon at Orthopedics and Joint Replacement at Mercy Medical Center. Board Certified, Dr. Ciotola’s extensive expertise in anterior hip replacement makes him one of the most sought-after orthopedic surgeons in the Baltimore region for hip replacement. Dr. Ciotola also specializes in knee replacement and knee resurfacing using MAKO® robotic arm technology, ACL reconstruction and shoulder/upper extremity surgeries including total shoulder replacement and the LRTI procedure to relieve arthritis of the thumb. Dr. Joseph Ciotola’s dedication to providing advanced orthopedic techniques helped bring anterior hip replacement to Orthopedics and Joint Replacement at Mercy. Dr. Ciotola, who is one of the first orthopedic surgeons in Baltimore to perform anterior hip replacement, teaches orthopedic surgeons throughout the country how to perform this minimally invasive approach to hip replacement. Many of his patients have expressed their gratitude and satisfaction by recommending Dr. Ciotola to family, friends and even strangers who are in need of a hip replacement. Dr. Joseph Ciotola is dedicated to providing his patients the best orthopedic care possible. Patients turn to Dr. Ciotola for his clinical expertise when they have hip or knee pain. His great compassion and concern for helping relieve their pain provides patients with the confidence that they will be able to return to their daily routines. Dr. Ciotola works individually with patients to develop the best treatment options to help with the return to normal activities.
Juergen Hahn, Department Head of Biomedical Engineering at Rensselaer Polytechnic Institute, is a trailblazer in the use of big data methods to improve the diagnosis and treatment of Autism. His research focuses on the use of machine-learning algorithms to analyze complex biological and biomedical systems. He previously developed a physiological test for autism after discovering patterns with certain metabolites in the blood that can accurately predict diagnosis. He is applying that same approach to other areas of autism research including correlating conditions and assessing the effectiveness of possible medical treatments.
Co-Director & Associate Research Professor
Laboratory capacity-building, Public health preparedness, International Health Regulations/GHSA implementation, Biosecurity and biosafety, Multisectoral coordination for disease detection and response, Viral pathogenesis
Associate research professor with the department of microbiology and a member of the Center for Global Health Science and Security at Georgetown University Medical Center. She focuses on research and tools to strengthen global capacities for public health preparedness and response. She has also worked on issues related to medical emergency preparedness, and the consequences of biological, chemical, and radiological exposures during military service. Fisher is a microbiologist by training and an expert in infectious diseases.
Kamala H. Littleton, M.D., is an expert orthopedic surgeon with Orthopedics and Joint Replacement at Mercy Medical Center in Baltimore, Maryland. Board Certified, Dr. Littleton specializes in joint replacement and reconstruction for the hip, knee and shoulder, including: Anterior hip replacement MAKO® knee resurfacing and knee replacement Minimally invasive total knee replacement ACL reconstruction Shoulder surgery and reconstruction Dr. Kamala Littleton is committed to providing her patients some of the best treatment options for their joint, hip, knee and shoulder pain. Dr. Littleton offers years of experience and specialized training to perform anterior hip replacement as well as MAKO knee resurfacing and knee replacement. These innovative orthopedic procedures enable her to help patients reduce their hip or knee pain so they can get back to normal daily activities. Dr. Kamala Littleton leads The Women’s Orthopedic Program at Mercy, which was developed to focus on the diagnosis and treatment of orthopedic conditions which most frequently affect women. Dr. Littleton recognizes that women have hormonal, anatomical and biomechanical characteristics that make them more vulnerable to certain orthopedic injuries and diseases. Some of the conditions more common to women include ACL tears, arthritis and osteoporosis. Prevention, treatment and avoiding reoccurrence are Dr. Littleton’s focus when treating women for their joint conditions. Her conservative approach coupled with her surgical expertise make her a top choice for patients seeking relief from hip, knee and shoulder pain.
Clinical Physical Therapist, CDE
Exercise, aging adults, balance dysfunction, painful orthopedic conditions
Diabetes, Diabetes & Endocrinology, Diabetes and Adults, Type 2 Diabetes, Type 1 Diabetes, Insulin, Diabetes Management, Diabetes Self-management, Exercise, Diabetes and exercise
alcohol use, alcohol use disorder, harm reduction, , Alcohol Use, Alcohol Use Disorder, harm reduction, moderate alcohol consumption, Mindfulness, reductions in drinking, alternatives to Alcoholics Anonymous, behavioral therapy for alcohol, Statistics, alc
Dr. Katie Witkiewitz is a Professor of Psychology at the University of New Mexico with a joint appointment at the Center on Alcoholism, Substance Abuse, and Addictions. The underlying theme of her research is the development of empirically-based models of alcohol use disorder, with an emphasis on harm reduction and the application of person-centered models to better understand individual changes in alcohol use over time. Her recent work has focused on novel definitions of alcohol use disorder treatment outcomes that focus on reductions in drinking, as an alternative to an abstinence-only model of alcohol recovery. Dr. Witkiewitz is also a licensed clinical psychologist and has worked extensively on the development of a theoretical model of biopsychosocial influences on alcohol use and relapse. This research has led to her collaborative work on the development and evaluation of mindfulness-based interventions for alcohol and drug use disorders. She has conducted numerous empirical studies on the prediction of alcohol and drug relapse following treatment, mechanisms of successful alcohol treatment outcomes, as well as the development of behavioral interventions to treat addiction. Her research has been supported by grants from the National Institute on Mental Health, the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism and the National Cancer Institute, totaling over $22 million in research funding since 2004. Dr. Witkiewitz was born in Rochester New York and graduated Summa Cum Laude with a Bachelor of Arts degree in psychology from the State University of New York at Potsdam in 1999. She completed a Masters of Arts degree at the University of Montana in 2000 and her doctoral degree at the University of Washington in 2005 under the direction of Dr. G. Alan Marlatt. To date, she has authored 5 books, over 185 peer-reviewed publications and book chapters, and she has given over 75 presentations and invited talks.
Dr Katy Hayward is one of the leading political sociologists on the island of Ireland, and is a Reader in Sociology, and Senior Research Fellow at the Senator George J. Mitchell Institute for Global Peace, Security and Justice at Queen’s University Belfast. Dr Hayward’s research focuses on conflict/post-conflict transitions and is actively interdisciplinary, traversing fields of border studies, conflict studies, European studies, and Irish studies. This means that she is particularly well-placed to speak about the implications of Brexit for the island of Ireland, and Northern Ireland in particular, European integration, political violence, and the application of discourse analysis.
Diabetes Clinical Nurse Specialist, CDE
Diabetes education, care and support, in inpatient and outpatient settings
Insulin Pump Therapy, CGM, Diabetes, Diabetes & Endocrinology, Type 2 Diabetes, Type 1 Diabetes, Diabetes Management, Diabetes Self-management
Jacobs Family Chair in Immunology
Cancer immunology, immunotherapy, cancer vaccines, biotech, multiple myeloma, medical oncology, medical research
Cancer, Cancer Immunology, immunotheraphy, Cancer Vaccines, Biotech, mutiple myeloma, Medical Oncology, Medical Research
Psychologist and Director, Stress Trauma and Resil
Specializes in mental health, stress, trauma, addiction treatment
Mental Health, Behavioral Health, Stress, stress and health, Stress and Anxiety, Stress And Depression, trauma exposure, addiction treatment, Family Stress, work stress
Kenneth J. Sher, Ph.D., is a nationally renowned scholar, researcher, and mentor whose work has greatly advanced our understanding of the etiology and course of alcohol use disorder (AUD), particularly as it relates to personality traits and their evolution. Dr. Sher has been at the forefront of research on personality, alcohol misuse among college students, and the behavioral pharmacology of alcohol. He is also a highly regarded expert in longitudinal research methodology. Over the course of his career, Dr. Sher has studied a wide range of topics contributing substantially to our understanding of the development of alcohol and other substance misuse. He has examined risk mechanisms that influence AUD onset and progression, premorbid predictors of future AUD (e.g., cognitive mechanisms and individual differences in the psychopharmacological responses to alcohol), and the involvement of family history of alcoholism in multiple etiological pathways to AUDs. His diverse research interests include: personality, as well as developmental changes in personality, as predictors of alcohol misuse and AUD; gene-environment interactions in the development of AUD; and predictors and consequences of binge drinking and alcohol misuse among college students (including 21st birthday drinking and other extreme drinking occasions). Dr. Sher has also investigated the phenomenon of “maturing out” of alcohol problems, demonstrating that maturing out is associated with differences in age-related personality changes that are accompanied by decreased impulsivity and neuroticism and is not merely a consequence of constrained opportunity occasioned by the assumption of adult roles. Dr. Sher had led two major ongoing longitudinal cohort studies that have followed individuals beginning in their freshman year of college and into mid-life. In addition to the development of AUD, this research tracks drug use and comorbid psychiatric disorders. A particularly innovative aspect of this work is the incorporation of genotyping which may provide key information on individual differences in susceptibility to AUD. In addition to using traditional survey approaches, Dr. Sher’s research employs event-based data to capture the momentary moods, motivational states, and cues that precede drinking events. This work is critical to understanding transient influences on drinking behavior and related consequences on a given occasion. A major focus of his current work is the critical evaluation of existing diagnostic approaches and development of empirically-based criteria and algorithms for AUD diagnosis. This research holds promise for improving AUD diagnosis in clinical practice, and advancing research on the causes and correlates of AUD. Dr. Sher has been continually funded by NIAAA for more than 30 years. He has had more than 250 papers published in peer-reviewed journals and he has authored and edited several books. Dr. Sher earned his undergraduate degree from Antioch College, his Ph.D. in clinical psychology from Indiana University, and completed clinical internship training at Brown University. He is the Curators’ Distinguished Professor of Psychological Sciences at the University of Missouri, where he directs a pre and postdoctoral training program in alcohol research.
Director, Comprehensive Sports Concussion Program
Expertise includes acute concussions; impact-related neck and upper spinal cord injuries; wide-ranging post-concussion symptoms from sports, the battlefield, car collisions, falls injuries etc. for all age groups
Concussions, neck injuries, upper spinal cord injuries, Lifebridge Health, Sinai, Northwest Hospital
Dr. Crutchfield, a nationally known expert on concussions and traumatic brain injury, directs LifeBridge Health’s Comprehensive Sports Concussion Program. He has served as an independent neurologist for many professional sports leagues and is board certified in psychiatry and neurology. He is a faculty appointee at the Uniformed Services University of Health Sciences and is a researcher and consultant to the U.S. military regarding the effects of traumatic brain injuries.
Kevin M. Audlin, M.D., is a Board Certified, experienced doctor and skilled surgeon in The Gynecology Center at Mercy Medical Center in Baltimore, Maryland. He also serves as Director of The Endometriosis Center at Mercy, a division of The Gynecology Center, focused primarily on the diagnosis and treatment of endometrial and fibroid disorders. Dr. Audlin has presented his surgical techniques and endometriosis findings at many national and international conferences. Throughout Dr. Kevin Audlin’s medical career he has cared for and managed the GYN health needs of women in the neighborhoods of Towson, Overlea and Reisterstown. As a result of years of practice and thousands of annual patient exam visits, Drs. Audlin and Barrueto have believed there was a clear need for more focused attention on endometriosis and other pelvic reconstruction conditions. They established The Endometriosis Center at Mercy so that women would have access to state-of-the-art treatment options, including laparoscopic and robotic minimally invasive surgical techniques focusing on excision of endometriosis while preserving the uterus and fertility whenever possible. Mercy offers fully appointed surgery suites equipped with leading edge technology, as well as recovery and inpatient rooms for post-surgical recovery that are welcoming and provide a homelike atmosphere for women and their loved ones. Dr. Audlin also is the first doctor in the mid-Atlantic region to use the groundbreaking low impact laparoscopic surgery to treat GYN conditions. This state-of-the-art minimally invasive technique utilizes micro surgical tools and 3 mm incisions, resulting in 40% or greater decrease in incision size than typical laparoscopic surgery. Low impact laparoscopic surgery incisions are approximately the length of a sesame seed. Low impact laparoscopy also can reduce the effects of surgery since it requires less inflation of the abdomen during surgery and uses micro-fine tools. This groundbreaking technique in coordination with the use of 3D imagery and NBI technology most often provides Dr. Audlin the opportunity to offer the best cosmetic options as well as leading edge management of many common gynecologic problems. This type of surgery may be used for endometriosis, hysterectomy, myomectomy, ovarian cysts and oophorectomy (removal of one or both ovaries). Dr. Audlin will use your medical history, risk factor and a thorough examination to help determine whether low impact laparoscopy is a suitable treatment option for your condition. How do you select the best doctor for your GYN care, especially if you have been diagnosed with endometriosis, fibroids, or other endoscopic and pelvic reconstruction conditions? Dr. Audlin encourages women to carefully select a doctor who is Board Certified, is specially trained in the care of routine and complex gynecologic diagnoses and a doctor who is extensively educated and experienced in minimally invasive surgical treatment options. Named a "Top Doc" by Baltimore magazine, Dr. Kevin Audlin is proud his medical education and clinical achievements have given him first-hand knowledge to care for women’s GYN needs. He also believes concern, a comforting bedside manner, compassion and treating women with dignity and respect are at the heart of Mercy care. Dr. Audlin has in-depth training and experience in treating the many levels of gynecologic care – from routine annual exams to pelvic reconstruction using the da Vinci Robot. Minimally invasive procedures using laparoscopic and robotic surgery have become the gold standard of care to treat many GYN conditions. Dr. Audlin has exceptional skill and knowledge in treating Interstitial Cystitis, a painful bladder condition. One treatment option that requires the expertise of a gynecologist like Dr. Audlin is called sacral nerve stimulation. This is where a thin wire is put in place and delivers an electrical impulse to the bladder to help it perform properly. This procedure is often compared to what a pacemaker does for the heart.
Dr. Ley s developed a heart vaccine that reduces or prevents inflammation in arteries and, in turn, plaque buildup. If successful, his work will result in the first vaccine to protect against heart disease.
Inflammation, Heart Disease, Vaccine, chronic inflammation, Integrins
Dr. Ley joined LJI in 2007 as the founding Division Head of the Division of Inflammation Biology. Dr. Ley received his B.S. from Altkönigschule-Gymnasium, Kronberg, Germany in 1976. In 1982, he received his M.D. from the Julius-Maximilians-Universität, Würzburg, Germany. Dr. Ley began his postdoctoral training from 1983 to 1987 at the Freie Universität Berlin, Germany. From 1987 to 1989, Dr. Ley was a visiting research scientist at the University of California, San Diego and returned to Freie Universität Berlin until 1994, when he joined the faculty of the University of Virginia. From 2001-2007, he was director of the Robert M Berne Cardiovascular Research Center at the University of Virginia.
Deputy Director, Chair of Gynecologic Oncology
Ovarian cancer, uterine cancer, cervical cancer, vaginal cancer, vulvar cancer, women’s cancers, immunotherapy, cancer vaccines, cancer therapies
Cancer, Cancer Therapy, Immunotherapy, Cancer Vaccines, Vaginal Cancer, Cervical Cancer, Ovarian Cancer, Uterine Cancer
Deputy Director, Chair of Gynecologic Oncology and the M. Steven Piver Professor of Gynecologic Oncology, Roswell Park Cancer Institute Areas of expertise: Ovarian cancer, uterine cancer, cervical cancer, vaginal cancer, vulvar cancer, women’s cancers, immunotherapy, cancer vaccines, cancer therapies